C60 fullerene - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	C60 fullerene	go back to main search page
Accession:	CHEBI:33128	browse the term
Definition:	A fullerene that has formula C60.
Synonyms:	related_synonym:	Buckminsterfulleren; Buckyball; Formula=C60; InChI=1S/C60/c1-2-5-6-3(1)8-12-10-4(1)9-11-7(2)17-21-13(5)23-24-14(6)22-18(8)28-20(12)30-26-16(10)15(9)25-29-19(11)27(17)37-41-31(21)33(23)43-44-34(24)32(22)42-38(28)48-40(30)46-36(26)35(25)45-39(29)47(37)55-49(41)51(43)57-52(44)50(42)56(48)59-54(46)53(45)58(55)60(57)59; InChIKey=XMWRBQBLMFGWIX-UHFFFAOYSA-N; SMILES=c12c3c4c5c1c1c6c7c2c2c8c3c3c9c4c4c%10c5c5c1c1c6c6c%11c7c2c2c7c8c3c3c8c9c4c4c9c%10c5c5c1c1c6c6c%11c2c2c7c3c3c8c4c4c9c5c1c1c6c2c3c41; [5,6]fullerene-C60-Ih; [60-Ih]fullerene; buckminsterfulereno; buckminsterfullerene; footballene; fullerene 60; soccerballene
	xref:	Beilstein:5901022; CAS:99685-96-8; Chemspider:110185; Gmelin:100331
	xref_mesh:	MESH:C069837
	xref:	PMID:22498298; PMID:25118710; Reaxys:5901022

show annotations for term's descendants Sort by:
Rat (1614) Mouse (1552) Human (1549) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (1614)

C60 fullerene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 1700009N14 gene like

increases expression

fullerene C60 results in increased expression of 1700009N14RIKL mRNA

NCBI chr 5:54,456,005...54,457,381
Ensembl chr 5:54,455,893...54,457,677

G

aladin WD repeat nucleoporin

increases expression

fullerene C60 results in increased expression of AAAS mRNA

NCBI chr 7:133,464,315...133,483,961
Ensembl chr 7:133,464,315...133,483,961

G

ATP binding cassette subfamily E member 1

decreases expression

fullerene C60 results in decreased expression of ABCE1 mRNA

NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489

G

ATP binding cassette subfamily F member 3

decreases expression

fullerene C60 results in decreased expression of ABCF3 mRNA

NCBI chr11:80,340,476...80,352,211
Ensembl chr11:80,339,977...80,352,211

G

abhydrolase domain containing 8

increases expression

fullerene C60 results in increased expression of ABHD8 mRNA

NCBI chr16:18,144,464...18,151,201
Ensembl chr16:18,144,464...18,157,667

G

ABL proto-oncogene 1, non-receptor tyrosine kinase

increases expression

fullerene C60 results in increased expression of ABL1 mRNA

NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065

G

ABL proto-oncogene 2, non-receptor tyrosine kinase

decreases expression

fullerene C60 results in decreased expression of ABL2 mRNA

NCBI chr13:68,673,702...68,770,846
Ensembl chr13:68,673,722...68,839,742

G

actin binding LIM protein family, member 2

increases expression

fullerene C60 results in increased expression of ABLIM2 mRNA

NCBI chr14:74,865,409...74,990,334
Ensembl chr14:74,866,281...74,990,334

G

actin-binding Rho activating protein

decreases expression

fullerene C60 results in decreased expression of ABRA mRNA

NCBI chr 7:72,970,187...72,974,255
Ensembl chr 7:72,970,186...72,974,255

G

acetyl-CoA acyltransferase 1A

decreases expression

fullerene C60 results in decreased expression of ACAA1 mRNA

NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624

G

acetyl-CoA carboxylase alpha

decreases expression

fullerene C60 results in decreased expression of ACACA mRNA

NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457

G

acyl-CoA binding domain containing 4

increases expression

fullerene C60 results in increased expression of ACBD4 mRNA

NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500

G

alkaline ceramidase 2

decreases expression

fullerene C60 results in decreased expression of ACER2 mRNA

NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614

G

acetylcholinesterase

decreases expression

fullerene C60 results in decreased expression of ACHE mRNA

NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651

G

acyl-CoA thioesterase 1

increases expression

fullerene C60 results in increased expression of ACOT1 mRNA

NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163

G

acid phosphatase 4

decreases expression

fullerene C60 results in decreased expression of ACP4 mRNA

NCBI chr 1:94,736,376...94,751,871
Ensembl chr 1:94,735,514...94,744,623

G

acid phosphatase 6, lysophosphatidic

decreases expression

fullerene C60 results in decreased expression of ACP6 mRNA

NCBI chr 2:184,711,975...184,733,067
Ensembl chr 2:184,711,619...184,733,017

G

actin-like 7a

decreases expression

fullerene C60 results in decreased expression of ACTL7A mRNA

NCBI chr 5:71,447,447...71,450,440
Ensembl chr 5:71,447,071...71,450,908

G

actin-like 7b

decreases expression

fullerene C60 results in decreased expression of ACTL7B mRNA

NCBI chr 5:71,445,532...71,446,920
Ensembl chr 5:71,445,534...71,446,920

G

actinin alpha 4

decreases expression

fullerene C60 results in decreased expression of ACTN4 mRNA

NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847

G

actin-related protein T2

decreases expression

fullerene C60 results in decreased expression of ACTRT2 mRNA

NCBI chr 5:165,236,092...165,237,492
Ensembl chr 5:165,236,086...165,237,629

G

aminoacylase 1

increases expression

fullerene C60 results in increased expression of ACY1 mRNA

NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682

G

ADAM metallopeptidase domain 19

decreases expression

fullerene C60 results in decreased expression of ADAM19 mRNA

NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105

G

ADAM metallopeptidase domain 7

decreases expression

fullerene C60 results in decreased expression of ADAM7 mRNA

NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201

G

ADAM metallopeptidase domain 8

increases expression

fullerene C60 results in increased expression of ADAM8 mRNA

NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801

G

ADAMTS-like 2

increases expression

fullerene C60 results in increased expression of ADAMTSL2 mRNA

NCBI chr 3:10,397,774...10,434,557
Ensembl chr 3:10,404,626...10,434,554

G

ADAMTS-like 4

increases expression

fullerene C60 results in increased expression of ADAMTSL4 mRNA

NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848

G

adenosine deaminase, RNA-specific, B1

decreases expression

fullerene C60 results in decreased expression of ADARB1 mRNA

NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852

G

adenylate cyclase 7

decreases expression

fullerene C60 results in decreased expression of ADCY7 mRNA

NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311

G

adducin 1

decreases expression

fullerene C60 results in decreased expression of ADD1 mRNA

NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182

G

adhesion G protein-coupled receptor E5

increases expression

fullerene C60 results in increased expression of ADGRE5 mRNA

NCBI chr19:24,397,972...24,418,648
Ensembl chr19:24,398,689...24,418,638

G

alcohol dehydrogenase, iron containing, 1

increases expression

fullerene C60 results in increased expression of ADHFE1 mRNA

NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517

G

adenosine A1 receptor

decreases expression

fullerene C60 results in decreased expression of ADORA1 mRNA

NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801

G

adrenoceptor alpha 1B

decreases expression

fullerene C60 results in decreased expression of ADRA1B mRNA

NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919

G

adrenoceptor alpha 1D

decreases expression

fullerene C60 results in decreased expression of ADRA1D mRNA

NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354

G

adrenoceptor alpha 2A

decreases expression

fullerene C60 results in decreased expression of ADRA2A mRNA

NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365

G

adrenoceptor alpha 2B

decreases expression

fullerene C60 results in decreased expression of ADRA2B mRNA

NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355

G

adrenoceptor alpha 2C

decreases expression

fullerene C60 results in decreased expression of ADRA2C mRNA

NCBI chr14:75,470,884...75,472,846
Ensembl chr14:75,471,143...75,472,846

G

adrenoceptor beta 1

increases expression

fullerene C60 results in increased expression of ADRB1 mRNA

NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259

G

AE binding protein 1

increases expression

fullerene C60 results in increased expression of AEBP1 mRNA

NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877

G

ALF transcription elongation factor 4

decreases expression

fullerene C60 results in decreased expression of AFF4 mRNA

NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751

G

ArfGAP with GTPase domain, ankyrin repeat and PH domain 1

increases expression

fullerene C60 results in increased expression of AGAP1 mRNA

NCBI chr 9:90,039,720...90,475,196
Ensembl chr 9:90,039,605...90,470,958

G

ArfGAP with GTPase domain, ankyrin repeat and PH domain 3

increases expression

fullerene C60 results in increased expression of AGAP3 mRNA

NCBI chr 4:10,674,746...10,724,848
Ensembl chr 4:10,674,064...10,725,244

G

advanced glycosylation end product-specific receptor

multiple interactions

[[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein] which results in increased expression of RAC1 protein; [fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein

NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078

G

AT hook containing transcription factor 1

decreases expression

fullerene C60 results in decreased expression of AHCTF1 mRNA

NCBI chr13:91,481,936...91,536,391
Ensembl chr13:91,481,936...91,536,391

G

adenosylhomocysteinase-like 1

increases expression

fullerene C60 results in increased expression of AHCYL1 mRNA

NCBI chr 2:195,294,149...195,328,586
Ensembl chr 2:195,294,153...195,345,815

G

aryl hydrocarbon receptor

decreases expression

fullerene C60 results in decreased expression of AHR mRNA

NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568

G

AIF family member 2

increases expression

fullerene C60 results in increased expression of AIFM2 mRNA

NCBI chr20:29,654,283...29,679,239
Ensembl chr20:29,652,927...29,679,236

G

A-kinase anchoring protein 3

decreases expression

fullerene C60 results in decreased expression of AKAP3 mRNA

NCBI chr 4:159,688,049...159,714,067
Ensembl chr 4:159,699,289...159,713,903

G

AT-hook transcription factor

decreases expression

fullerene C60 results in decreased expression of AKNA mRNA

NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017

G

AKNA domain containing 1

decreases expression

fullerene C60 results in decreased expression of AKNAD1 mRNA

NCBI chr 2:196,385,149...196,432,319
Ensembl chr 2:196,393,535...196,432,309

G

aldo-keto reductase family 1, member B1 (aldose reductase), pseudogene 1

increases expression

fullerene C60 results in increased expression of AKR1B1-PS1 mRNA

NCBI chr 6:45,089,717...45,090,928
Ensembl chr 6:45,089,864...45,090,767

G

aldo-keto reductase family 1, member C12-like 1

decreases expression

fullerene C60 results in decreased expression of AKR1C12L1 mRNA

NCBI chr17:65,937,834...65,948,344
Ensembl chr17:65,937,814...65,997,595

G

AKT1 substrate 1

increases expression

fullerene C60 results in increased expression of AKT1S1 mRNA

NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677

G

AKT serine/threonine kinase 2

increases expression

fullerene C60 results in increased expression of AKT2 mRNA

NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817

G

albumin

multiple interactions

fullerene C60 inhibits the reaction [ALB protein modified form results in increased expression of IL6 protein]; fullerene C60 promotes the reaction [ALB protein modified form results in increased expression of TNF protein]

NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836

G

aldehyde dehydrogenase 16 family, member A1

increases expression

fullerene C60 results in increased expression of ALDH16A1 mRNA

NCBI chr 1:95,626,727...95,639,808
Ensembl chr 1:95,613,558...95,640,131

G

aldehyde dehydrogenase 4 family, member A1

increases expression

fullerene C60 results in increased expression of ALDH4A1 mRNA

NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345

G

arachidonate 15-lipoxygenase

increases expression

fullerene C60 results in increased expression of ALOX15 mRNA

NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874

G

ALS2 C-terminal like

increases expression

fullerene C60 results in increased expression of ALS2CL mRNA

NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419

G

ALX homeobox 3

decreases expression

fullerene C60 results in decreased expression of ALX3 mRNA

NCBI chr 2:195,231,197...195,241,609
Ensembl chr 2:195,231,197...195,241,609

G

ameloblastin

decreases expression

fullerene C60 results in decreased expression of AMBN mRNA

NCBI chr14:19,601,761...19,614,382
Ensembl chr14:19,601,702...19,614,393

G

adhesion molecule with Ig like domain 1

decreases expression

fullerene C60 results in decreased expression of AMIGO1 mRNA

NCBI chr 2:195,823,138...195,828,593
Ensembl chr 2:195,823,042...195,829,585

G

amnion associated transmembrane protein

decreases expression

fullerene C60 results in decreased expression of AMN mRNA

NCBI chr 6:130,311,372...130,318,815
Ensembl chr 6:130,311,372...130,318,815

G

adenosine monophosphate deaminase 2

decreases expression

fullerene C60 results in decreased expression of AMPD2 mRNA

NCBI chr 2:195,707,609...195,720,454
Ensembl chr 2:195,707,610...195,720,271

G

angiopoietin-like 4

decreases expression

fullerene C60 results in decreased expression of ANGPTL4 mRNA

NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519

G

ankyrin repeat domain 13a

increases expression

fullerene C60 results in increased expression of ANKRD13A mRNA

NCBI chr12:41,798,196...41,828,327
Ensembl chr12:41,798,199...41,829,327

G

ankyrin repeat domain 33B

increases expression

fullerene C60 results in increased expression of ANKRD33B mRNA

NCBI chr 2:82,277,604...82,359,420
Ensembl chr 2:82,283,108...82,358,872

G

ankyrin repeat and sterile alpha motif domain containing 1A

increases expression

fullerene C60 results in increased expression of ANKS1A mRNA

NCBI chr20:5,963,658...6,117,139
Ensembl chr20:5,963,678...6,117,148

G

alanyl aminopeptidase, membrane

increases expression

fullerene C60 results in increased expression of ANPEP mRNA

NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789

G

annexin A6

increases expression

fullerene C60 results in increased expression of ANXA6 mRNA

NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433

G

adaptor related protein complex 1 subunit beta 1

increases expression

fullerene C60 results in increased expression of AP1B1 mRNA

NCBI chr14:79,879,482...79,930,778
Ensembl chr14:79,879,533...79,930,778

G

adaptor related protein complex 1 subunit mu 1

increases expression

fullerene C60 results in increased expression of AP1M1 mRNA

NCBI chr16:17,586,886...17,602,410
Ensembl chr16:17,584,730...17,602,403

G

adaptor related protein complex 1 subunit sigma 1

decreases expression

fullerene C60 results in decreased expression of AP1S1 mRNA

NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713

G

adaptor related protein complex 2 subunit alpha 1

decreases expression

fullerene C60 results in decreased expression of AP2A1 mRNA

NCBI chr 1:95,384,306...95,414,170
Ensembl chr 1:95,384,309...95,414,147

G

amyloid beta precursor protein binding family A member 2

increases expression

fullerene C60 results in increased expression of APBA2 mRNA

NCBI chr 1:118,053,270...118,286,858
Ensembl chr 1:118,103,219...118,285,699

G

APC regulator of WNT signaling pathway 2

decreases expression

fullerene C60 results in decreased expression of APC2 mRNA

NCBI chr 7:9,392,336...9,414,364
Ensembl chr 7:9,392,336...9,414,310

G

apolipoprotein A1

decreases expression
increases expression

fullerene C60 results in decreased expression of APOA1 mRNA
fullerene C60 results in increased expression of APOA1 mRNA

NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035

G

apolipoprotein A5

decreases expression

fullerene C60 results in decreased expression of APOA5 mRNA

NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816

G

apolipoprotein L9a

decreases expression

fullerene C60 results in decreased expression of APOL9A mRNA

NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649

G

apolipoprotein L domain containing 1

decreases expression

fullerene C60 results in decreased expression of APOLD1 mRNA

NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706

G

aquaporin 11

decreases expression

fullerene C60 results in decreased expression of AQP11 mRNA

NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725

G

aquaporin 3 (Gill blood group)

increases expression

fullerene C60 results in increased expression of AQP3 mRNA

NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720

G

ADP-ribosylation factor interacting protein 2

increases expression

fullerene C60 results in increased expression of ARFIP2 mRNA

NCBI chr 1:159,974,255...159,980,398
Ensembl chr 1:159,974,201...159,980,336

G

arginase 2

decreases expression

fullerene C60 results in decreased expression of ARG2 mRNA

NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378

G

Rho GTPase activating protein 10

affects expression

fullerene C60 affects the expression of ARHGAP10 mRNA

NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313

G

Rho GTPase activating protein 25

decreases expression

fullerene C60 results in decreased expression of ARHGAP25 mRNA

NCBI chr 4:119,896,844...119,974,982
Ensembl chr 4:119,896,844...119,974,982

G

Rho GTPase activating protein 27

increases expression

fullerene C60 results in increased expression of ARHGAP27 mRNA

NCBI chr10:88,280,470...88,313,225
Ensembl chr10:88,280,455...88,313,185

G

Rho GTPase activating protein 31

increases expression

fullerene C60 results in increased expression of ARHGAP31 mRNA

NCBI chr11:62,038,635...62,151,564
Ensembl chr11:62,038,635...62,151,564

G

Rho GTPase activating protein 33

decreases expression

fullerene C60 results in decreased expression of ARHGAP33 mRNA

NCBI chr 1:85,776,112...85,789,767
Ensembl chr 1:85,776,108...85,789,678

G

Rho guanine nucleotide exchange factor 11

increases expression

fullerene C60 results in increased expression of ARHGEF11 mRNA

NCBI chr 2:173,074,383...173,195,962
Ensembl chr 2:173,074,368...173,196,010

G

Rho guanine nucleotide exchange factor 12

increases expression

fullerene C60 results in increased expression of ARHGEF12 mRNA

NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366

G

Rho/Rac guanine nucleotide exchange factor 18

increases expression

fullerene C60 results in increased expression of ARHGEF18 mRNA

NCBI chr12:1,395,035...1,503,082
Ensembl chr12:1,395,088...1,503,081

G

Rho guanine nucleotide exchange factor 28

increases expression

fullerene C60 results in increased expression of ARHGEF28 mRNA

NCBI chr 2:29,263,888...29,560,595
Ensembl chr 2:29,263,886...29,560,672

G

Rho guanine nucleotide exchange factor 37

decreases expression

fullerene C60 results in decreased expression of ARHGEF37 mRNA

NCBI chr18:54,935,256...55,001,017
Ensembl chr18:54,949,110...55,000,669

G

Rho guanine nucleotide exchange factor 4

decreases expression

fullerene C60 results in decreased expression of ARHGEF4 mRNA

NCBI chr 9:36,861,800...37,005,079
Ensembl chr 9:36,861,835...37,005,075

G

Rho guanine nucleotide exchange factor 7

increases expression

fullerene C60 results in increased expression of ARHGEF7 mRNA

NCBI chr16:77,671,021...77,782,593
Ensembl chr16:77,671,023...77,782,697

G

AT-rich interaction domain 3B

decreases expression

fullerene C60 results in decreased expression of ARID3B mRNA

NCBI chr 8:58,193,268...58,240,901
Ensembl chr 8:58,193,418...58,238,318

G

ADP-ribosylation factor like GTPase 4D

affects expression

fullerene C60 affects the expression of ARL4D mRNA

NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836

G

armadillo repeat containing 6

increases expression

fullerene C60 results in increased expression of ARMC6 mRNA

NCBI chr16:19,191,106...19,201,528
Ensembl chr16:19,191,093...19,206,047

G

armadillo repeat containing, X-linked 1

increases expression

fullerene C60 results in increased expression of ARMCX1 mRNA

NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299

G

armadillo repeat containing, X-linked 6

decreases expression

fullerene C60 results in decreased expression of ARMCX6 mRNA

NCBI chr X:97,929,032...97,932,031
Ensembl chr X:97,929,041...97,931,977

G

actin related protein 2/3 complex, subunit 2

decreases expression

fullerene C60 results in decreased expression of ARPC2 mRNA

NCBI chr 9:75,820,782...75,851,471
Ensembl chr 9:75,820,770...75,851,471

G

arrestin domain containing 2

increases expression

fullerene C60 results in increased expression of ARRDC2 mRNA

NCBI chr16:18,601,897...18,606,029
Ensembl chr16:18,601,897...18,606,029

G

arylsulfatase B

increases expression

fullerene C60 results in increased expression of ARSB mRNA

NCBI chr 2:25,002,210...25,162,675
Ensembl chr 2:25,002,346...25,162,671

G

arylsulfatase L

increases expression

fullerene C60 results in increased expression of ARSL mRNA

NCBI chr 2:119,038,803...119,047,579
Ensembl chr 2:119,038,921...119,046,846

G

ankyrin repeat and SOCS box-containing 1

decreases expression

fullerene C60 results in decreased expression of ASB1 mRNA

NCBI chr 9:92,120,332...92,140,790
Ensembl chr 9:92,120,306...92,136,376

G

ankyrin repeat and SOCS box-containing 6

increases expression

fullerene C60 results in increased expression of ASB6 mRNA

NCBI chr 3:14,110,628...14,115,274
Ensembl chr 3:14,110,628...14,115,242

G

asialoglycoprotein receptor 1

decreases expression

fullerene C60 results in decreased expression of ASGR1 mRNA

NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631

G

ASH1 like histone lysine methyltransferase

decreases expression

fullerene C60 results in decreased expression of ASH1L mRNA

NCBI chr 2:174,346,267...174,483,057
Ensembl chr 2:174,346,150...174,483,055

G

acid sensing ion channel subunit 1

increases expression

fullerene C60 results in increased expression of ASIC1 mRNA

NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541

G

acid sensing ion channel subunit family member 4

decreases expression

fullerene C60 results in decreased expression of ASIC4 mRNA

NCBI chr 9:76,941,532...76,962,900
Ensembl chr 9:76,941,532...76,962,900

G

arginyltransferase 1

decreases expression

fullerene C60 results in decreased expression of ATE1 mRNA

NCBI chr 1:184,961,548...185,081,112
Ensembl chr 1:184,963,562...185,080,908

G

activating transcription factor 6

affects expression

fullerene C60 affects the expression of ATF6 mRNA

NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177

G

autophagy related 16-like 1

increases expression

fullerene C60 results in increased expression of ATG16L1 mRNA

NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529

G

ATPase cation transporting 13A2

increases expression

fullerene C60 results in increased expression of ATP13A2 mRNA

NCBI chr 5:153,292,722...153,312,143
Ensembl chr 5:153,292,751...153,312,139

G

ATPase Na+/K+ transporting subunit beta 3

decreases expression

fullerene C60 results in decreased expression of ATP1B3 mRNA

NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:96,910,309...96,941,598

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1

decreases expression

fullerene C60 results in decreased expression of ATP2A1 mRNA

NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3

increases expression

fullerene C60 results in increased expression of ATP2A3 mRNA

NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748

G

ATP synthase membrane subunit c locus 2

decreases expression

fullerene C60 results in decreased expression of ATP5MC2 mRNA

NCBI chr 7:133,791,341...133,799,713
Ensembl chr 7:133,791,342...133,799,733

G

ATP synthase membrane subunit c locus 3

decreases expression

fullerene C60 results in decreased expression of ATP5MC3 mRNA

NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279

G

ATPase H+ transporting accessory protein 2

affects expression

fullerene C60 affects the expression of ATP6AP2 mRNA

NCBI chr X:10,183,983...10,210,948
Ensembl chr X:10,183,068...10,210,918

G

ATPase H+ transporting V0 subunit a1

decreases expression

fullerene C60 results in decreased expression of ATP6V0A1 mRNA

NCBI chr10:85,935,802...85,989,901
Ensembl chr10:85,935,854...85,989,895

G

ATPase H+ transporting V0 subunit D1

decreases expression

fullerene C60 results in decreased expression of ATP6V0D1 mRNA

NCBI chr19:33,403,352...33,447,357
Ensembl chr19:33,403,355...33,447,450

G

ATPase, H+ transporting V0 subunit e2

decreases expression

fullerene C60 results in decreased expression of ATP6V0E2 mRNA

NCBI chr 4:77,484,868...77,488,016
Ensembl chr 4:77,482,226...77,488,777

G

ataxin 2-like

increases expression

fullerene C60 results in increased expression of ATXN2L mRNA

NCBI chr 1:181,078,293...181,090,079
Ensembl chr 1:181,078,288...181,089,686

G

arginine vasopressin

decreases expression

fullerene C60 results in decreased expression of AVP mRNA

NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425

G

arginine vasopressin receptor 2

decreases expression

fullerene C60 results in decreased expression of AVPR2 mRNA

NCBI chr X:151,633,501...151,636,155
Ensembl chr X:151,633,522...151,635,989

G

axin 2

increases expression

fullerene C60 results in increased expression of AXIN2 mRNA

NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231

G

beta-1,3-glucuronyltransferase 1

decreases expression

fullerene C60 results in decreased expression of B3GAT1 mRNA

NCBI chr 8:25,087,123...25,114,692
Ensembl chr 8:25,087,547...25,113,395

G

beta-1,4-N-acetyl-galactosaminyl transferase 4

decreases expression

fullerene C60 results in decreased expression of B4GALNT4 mRNA

NCBI chr 1:196,171,394...196,182,294
Ensembl chr 1:196,171,394...196,182,294

G

beta-1,4-galactosyltransferase 2

increases expression

fullerene C60 results in increased expression of B4GALT2 mRNA

NCBI chr 5:131,412,541...131,422,573
Ensembl chr 5:131,412,541...131,421,013

G

BAR/IMD domain containing adaptor protein 2

increases expression

fullerene C60 results in increased expression of BAIAP2 mRNA

NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134

G

brain abundant, membrane attached signal protein 1

decreases expression

fullerene C60 results in decreased expression of BASP1 mRNA

NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043

G

bromodomain adjacent to zinc finger domain, 2A

increases expression

fullerene C60 results in increased expression of BAZ2A mRNA

NCBI chr 7:523,204...560,911
Ensembl chr 7:523,265...560,659

G

Bardet-Biedl syndrome 1

increases expression

fullerene C60 results in increased expression of BBS1 mRNA

NCBI chr 1:202,184,812...202,204,118
Ensembl chr 1:202,186,125...202,204,086

G

Bardet-Biedl syndrome 4

decreases expression

fullerene C60 results in decreased expression of BBS4 mRNA

NCBI chr 8:59,731,912...59,765,408
Ensembl chr 8:59,731,912...59,765,607

G

BBX high mobility group box domain containing

affects expression

fullerene C60 affects the expression of BBX mRNA

NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251

G

basal cell adhesion molecule (Lutheran blood group)

increases expression

fullerene C60 results in increased expression of BCAM mRNA

NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403

G

BCAR1 scaffold protein, Cas family member

increases expression

fullerene C60 results in increased expression of BCAR1 mRNA

NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907

G

BCAS3, microtubule associated cell migration factor

increases expression

fullerene C60 results in increased expression of BCAS3 mRNA

NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080

G

branched chain keto acid dehydrogenase E1 subunit beta

decreases expression

fullerene C60 results in decreased expression of BCKDHB mRNA

NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812

G

Bcl2-like 1

decreases expression

fullerene C60 results in decreased expression of BCL2L1 mRNA

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479

G

Bcl2-like 10

decreases expression

fullerene C60 results in decreased expression of BCL2L10 mRNA

NCBI chr 8:76,107,326...76,113,373
Ensembl chr 8:76,107,326...76,113,367

G

beta-carotene oxygenase 1

decreases expression

fullerene C60 results in decreased expression of BCO1 mRNA

NCBI chr19:45,149,250...45,186,102
Ensembl chr19:45,149,265...45,186,101

G

3-hydroxybutyrate dehydrogenase 1

increases expression

fullerene C60 results in increased expression of BDH1 mRNA

NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671

G

brain-derived neurotrophic factor

decreases expression

fullerene C60 results in decreased expression of BDNF mRNA; fullerene C60 results in decreased expression of BDNF protein

NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615

G

brain expressed, associated with NEDD4, 1

increases expression

fullerene C60 results in increased expression of BEAN1 mRNA

NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537

G

bestrophin 2

decreases expression

fullerene C60 results in decreased expression of BEST2 mRNA

NCBI chr19:23,142,324...23,148,351
Ensembl chr19:23,141,602...23,148,339

G

brain expressed X-linked 3

decreases expression

fullerene C60 results in decreased expression of BEX3 mRNA

NCBI chr X:99,273,270...99,274,799
Ensembl chr X:99,273,161...99,274,800

G

BICD cargo adaptor 1

decreases expression

fullerene C60 results in decreased expression of BICD1 mRNA

NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434

G

basic helix-loop-helix ARNT like 1

decreases expression

fullerene C60 results in decreased expression of BMAL1 mRNA

NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231

G

bone morphogenetic protein 2

decreases expression

fullerene C60 results in decreased expression of BMP2 mRNA

NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397

G

BLOC-1 related complex subunit 8

increases expression

fullerene C60 results in increased expression of BORCS8 mRNA

NCBI chr16:19,274,305...19,280,969
Ensembl chr16:19,274,023...19,280,339

G

bisphosphoglycerate mutase

decreases expression

fullerene C60 results in decreased expression of BPGM mRNA

NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581

G

BRCA1/BRCA2-containing complex subunit 3

decreases expression

fullerene C60 results in decreased expression of BRCC3 mRNA

NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080

G

bassoon (presynaptic cytomatrix protein)

decreases expression

fullerene C60 results in decreased expression of BSN mRNA

NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819

G

BTB domain containing 10

decreases expression

fullerene C60 results in decreased expression of BTBD10 mRNA

NCBI chr 1:167,431,311...167,489,320
Ensembl chr 1:167,431,329...167,489,916

G

BTB domain containing 2

increases expression

fullerene C60 results in increased expression of BTBD2 mRNA

NCBI chr 7:9,058,609...9,075,341
Ensembl chr 7:9,060,788...9,075,344

G

BUD13 homolog

decreases expression

fullerene C60 results in decreased expression of BUD13 mRNA

NCBI chr 8:46,575,124...46,590,964
Ensembl chr 8:46,575,115...46,590,958

G

C1GALT1-specific chaperone 1

decreases expression

fullerene C60 results in decreased expression of C1GALT1C1 mRNA

NCBI chr X:117,378,123...117,382,620
Ensembl chr X:117,375,525...117,382,787

G

complement C1q C chain

decreases expression

fullerene C60 results in decreased expression of C1QC mRNA

NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017

G

C1q and TNF related 1

decreases expression

fullerene C60 results in decreased expression of C1QTNF1 mRNA

NCBI chr10:103,660,319...103,681,662
Ensembl chr10:103,660,327...103,681,660

G

complement C2

increases expression

fullerene C60 results in increased expression of C2 mRNA

NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505

G

C2 calcium-dependent domain containing 2

decreases expression

fullerene C60 results in decreased expression of C2CD2 mRNA

NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739

G

C2CD2-like

increases expression

fullerene C60 results in increased expression of C2CD2L mRNA

NCBI chr 8:44,648,074...44,658,856
Ensembl chr 8:44,648,079...44,658,340

G

C2 calcium-dependent domain containing 4D

increases expression

fullerene C60 results in increased expression of C2CD4D mRNA

NCBI chr 2:181,999,778...182,001,941
Ensembl chr 2:181,997,078...182,002,087

G

complement C6

increases expression

fullerene C60 results in increased expression of C6 mRNA

NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275

G

Cdk5 and Abl enzyme substrate 1

decreases expression

fullerene C60 results in decreased expression of CABLES1 mRNA

NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181

G

cache domain containing 1

affects expression

fullerene C60 affects the expression of CACHD1 mRNA

NCBI chr 5:115,411,833...115,637,312
Ensembl chr 5:115,411,071...115,657,505

G

calcium voltage-gated channel subunit alpha1 D

decreases expression

fullerene C60 results in decreased expression of CACNA1D mRNA

NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215

G

calcium voltage-gated channel subunit alpha1 E

decreases expression

fullerene C60 results in decreased expression of CACNA1E mRNA

NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450

G

calcium voltage-gated channel subunit alpha1 G

decreases expression

fullerene C60 results in decreased expression of CACNA1G mRNA

NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752

G

calcium voltage-gated channel subunit alpha1 I

decreases expression

fullerene C60 results in decreased expression of CACNA1I mRNA

NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688

G

calcium voltage-gated channel auxiliary subunit alpha2delta 3

decreases expression

fullerene C60 results in decreased expression of CACNA2D3 mRNA

NCBI chr16:4,098,439...4,912,498
Ensembl chr16:4,098,445...4,912,351

G

calbindin 2

decreases expression

fullerene C60 results in decreased expression of CALB2 mRNA

NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438

G

calmodulin 3

decreases expression

fullerene C60 results in decreased expression of CALM3 mRNA

NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207

G

calmodulin-like 3

decreases expression

fullerene C60 results in decreased expression of CALML3 mRNA

NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175

G

calcyon neuron-specific vesicular protein

decreases expression

fullerene C60 results in decreased expression of CALY mRNA

NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:194,862,672...194,873,551

G

calcium/calmodulin-dependent protein kinase IG

increases expression

fullerene C60 results in increased expression of CAMK1G mRNA

NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556

G

calcium/calmodulin-dependent protein kinase IV

decreases expression

fullerene C60 results in decreased expression of CAMK4 mRNA

NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487

G

calnexin

decreases expression

fullerene C60 results in decreased expression of CANX mRNA

NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821

G

calpain 1

increases expression

fullerene C60 results in increased expression of CAPN1 mRNA

NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177

G

carbonic anhydrase 1

decreases expression

fullerene C60 results in decreased expression of CAR1 mRNA

NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208

G

carbonic anhydrase 5A

increases expression

fullerene C60 results in increased expression of CA5A mRNA

NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906

G

caspase recruitment domain family, member 10

increases expression

fullerene C60 results in increased expression of CARD10 mRNA

NCBI chr 7:110,330,460...110,371,551
Ensembl chr 7:110,330,408...110,359,224

G

coactivator-associated arginine methyltransferase 1

decreases expression

fullerene C60 results in decreased expression of CARM1 mRNA

NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689

G

CART prepropeptide

decreases expression

fullerene C60 results in decreased expression of CARTPT mRNA

NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713

G

cask-interacting protein 2

increases expression

fullerene C60 results in increased expression of CASKIN2 mRNA

NCBI chr10:101,027,196...101,041,429
Ensembl chr10:101,027,260...101,041,414

G

caspase 3

increases cleavage
increases activity

fullerene C60 analog results in increased cleavage of CASP3 protein
fullerene C60 metabolite results in increased activity of CASP3 protein

PMID:18926839 PMID:22108244

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

caspase 8 associated protein 2

increases expression

fullerene C60 results in increased expression of CASP8AP2 mRNA

NCBI chr 5:47,014,501...47,052,276
Ensembl chr 5:47,014,667...47,052,275

G

catalase

decreases activity

fullerene C60 metabolite results in decreased activity of CAT protein

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

caveolin 3

decreases expression

fullerene C60 results in decreased expression of CAV3 mRNA

NCBI chr 4:145,582,168...145,598,142
Ensembl chr 4:145,582,060...145,598,137

G

CBFA2/RUNX1 partner transcriptional co-repressor 2

decreases expression

fullerene C60 results in decreased expression of CBFA2T2 mRNA

NCBI chr 3:142,936,945...143,043,205
Ensembl chr 3:142,936,985...143,043,197

G

core-binding factor subunit beta

decreases expression

fullerene C60 results in decreased expression of CBFB mRNA

NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751

G

chibby family member 2

decreases expression

fullerene C60 results in decreased expression of CBY2 mRNA

NCBI chr15:50,909,435...51,004,449
Ensembl chr15:50,909,436...50,934,633

G

coiled-coil domain containing 124

decreases expression

fullerene C60 results in decreased expression of CCDC124 mRNA

NCBI chr16:18,566,745...18,572,564
Ensembl chr16:18,566,745...18,572,564

G

coiled-coil domain containing 136

increases expression

fullerene C60 results in increased expression of CCDC136 mRNA

NCBI chr 4:57,997,825...58,027,598
Ensembl chr 4:57,997,853...58,027,646

G

coiled-coil domain containing 187

decreases expression

fullerene C60 results in decreased expression of CCDC187 mRNA

NCBI chr 3:9,070,192...9,127,001
Ensembl chr 3:9,070,185...9,126,946

G

coiled-coil domain containing 22

increases expression

fullerene C60 results in increased expression of CCDC22 mRNA

NCBI chr X:14,898,296...14,910,244
Ensembl chr X:14,898,296...14,910,244

G

coiled-coil domain containing 33

increases expression

fullerene C60 results in increased expression of CCDC33 mRNA

NCBI chr 8:58,434,798...58,534,338
Ensembl chr 8:58,435,661...58,534,370

G

coiled-coil domain containing 60

increases expression

fullerene C60 results in increased expression of CCDC60 mRNA

NCBI chr12:40,314,687...40,480,338
Ensembl chr12:40,314,713...40,480,225

G

coiled-coil domain containing 77

increases expression

fullerene C60 results in increased expression of CCDC77 mRNA

NCBI chr 4:153,534,184...153,566,059
Ensembl chr 4:153,534,187...153,566,545

G

coiled-coil domain containing 91

decreases expression

fullerene C60 results in decreased expression of CCDC91 mRNA

NCBI chr 4:180,402,327...180,574,364
Ensembl chr 4:180,402,376...180,574,364

G

coiled-coil domain containing 9B

decreases expression

fullerene C60 results in decreased expression of CCDC9B mRNA

NCBI chr 3:105,736,120...105,745,039
Ensembl chr 3:105,739,174...105,744,697

G

coiled-coil alpha-helical rod protein 1

increases expression

fullerene C60 results in increased expression of CCHCR1 mRNA

NCBI chr20:3,205,675...3,218,437
Ensembl chr20:3,205,676...3,218,308

G

C-C motif chemokine ligand 12

increases expression

fullerene C60 results in increased expression of CCL12 mRNA

NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780

G

C-C motif chemokine ligand 17

increases expression

fullerene C60 results in increased expression of CCL17 mRNA

NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819

G

C-C motif chemokine ligand 19

decreases expression

fullerene C60 results in decreased expression of CCL19 mRNA

NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308

G

C-C motif chemokine ligand 2

increases expression

fullerene C60 results in increased expression of CCL2 mRNA

NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226

G

C-C motif chemokine ligand 22

increases expression

fullerene C60 results in increased expression of CCL22 mRNA

NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400

G

C-C motif chemokine ligand 3

increases expression

fullerene C60 results in increased expression of CCL3 mRNA

NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938

G

C-C motif chemokine ligand 7

increases expression

fullerene C60 results in increased expression of CCL7 mRNA

PMID:19167457 PMID:20471445

NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303

G

C-C motif chemokine ligand 9

increases expression

fullerene C60 results in increased expression of CCL6 mRNA

NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369

G

CCM2 scaffold protein

increases expression

fullerene C60 results in increased expression of CCM2 mRNA

NCBI chr14:81,418,418...81,464,114
Ensembl chr14:81,418,236...81,464,116

G

cellular communication network factor 1

increases expression

fullerene C60 results in increased expression of CCN1 mRNA

NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484

G

cyclin F

increases expression

fullerene C60 results in increased expression of CCNF mRNA

NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101

G

cyclin L1

decreases expression

fullerene C60 results in decreased expression of CCNL1 mRNA

NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368

G

C-C motif chemokine receptor 9

decreases expression

fullerene C60 results in decreased expression of CCR9 mRNA

NCBI chr 8:123,396,157...123,410,199
Ensembl chr 8:123,395,813...123,413,969

G

chaperonin containing TCP1 subunit 6A

increases expression

fullerene C60 results in increased expression of CCT6A mRNA

NCBI chr12:26,872,736...26,883,125
Ensembl chr12:26,872,574...26,883,337

G

chaperonin containing TCP1 subunit 7

decreases expression

fullerene C60 results in decreased expression of CCT7 mRNA

NCBI chr 4:117,989,232...118,006,478
Ensembl chr 4:117,989,232...118,006,580

G

CD19 molecule

increases expression

fullerene C60 results in increased expression of CD19 mRNA

NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975

G

Cd6 molecule

increases expression

fullerene C60 results in increased expression of CD6 mRNA

NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634

G

Cd7 molecule

decreases expression

fullerene C60 results in decreased expression of CD7 mRNA

NCBI chr10:106,304,046...106,306,963
Ensembl chr10:106,304,056...106,306,967

G

CD79b molecule

increases expression

fullerene C60 results in increased expression of CD79B mRNA

NCBI chr10:91,239,354...91,242,500
Ensembl chr10:91,239,356...91,242,625

G

cell division cycle 25B

increases expression

fullerene C60 results in increased expression of CDC25B mRNA

NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272

G

CDC42 binding protein kinase beta

increases expression

fullerene C60 results in increased expression of CDC42BPB mRNA

NCBI chr 6:130,333,712...130,416,631
Ensembl chr 6:130,333,712...130,416,377

G

CDC42 binding protein kinase gamma

increases expression

fullerene C60 results in increased expression of CDC42BPG mRNA

NCBI chr 1:203,608,339...203,628,502
Ensembl chr 1:203,608,574...203,628,502

G

CDC42 small effector 1

increases expression

fullerene C60 results in increased expression of CDC42SE1 mRNA

NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028

G

cadherin 16

decreases expression

fullerene C60 results in decreased expression of CDH16 mRNA

NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007

G

cyclin-dependent kinase 11B

increases expression

fullerene C60 results in increased expression of CDK11B mRNA

NCBI chr 5:166,212,761...166,238,883
Ensembl chr 5:166,212,829...166,238,876

G

cyclin-dependent kinase 14

decreases expression

fullerene C60 results in decreased expression of CDK14 mRNA

NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861

G

cyclin-dependent kinase 18

decreases expression

fullerene C60 results in decreased expression of CDK18 mRNA

NCBI chr13:43,555,597...43,582,210
Ensembl chr13:43,556,748...43,588,525

G

cyclin-dependent kinase 2 associated protein 1

decreases expression

fullerene C60 results in decreased expression of CDK2AP1 mRNA

NCBI chr12:32,249,752...32,258,483
Ensembl chr12:32,249,747...32,258,479

G

cyclin-dependent kinase inhibitor 1A

decreases expression
increases expression

fullerene C60 results in decreased expression of CDKN1A mRNA
fullerene C60 analog results in increased expression of CDKN1A protein

PMID:19167457 PMID:20045429

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 2A

increases expression

fullerene C60 analog results in increased expression of CDKN2A protein

NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149

G

cell adhesion associated, oncogene regulated

decreases expression

fullerene C60 results in decreased expression of CDON mRNA

NCBI chr 8:33,775,123...33,861,635
Ensembl chr 8:33,806,183...33,859,033

G

chromatin licensing and DNA replication factor 1

increases expression

fullerene C60 results in increased expression of CDT1 mRNA

NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659

G

CEA cell adhesion molecule 20

decreases expression

fullerene C60 results in decreased expression of CEACAM20 mRNA

NCBI chr 1:79,622,077...79,643,782
Ensembl chr 1:79,622,077...79,643,782

G

CCAAT/enhancer binding protein alpha

increases expression

fullerene C60 results in increased expression of CEBPA mRNA

NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412

G

CCAAT/enhancer binding protein beta

decreases expression

fullerene C60 results in decreased expression of CEBPB mRNA

NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473

G

CCAAT/enhancer binding protein delta

decreases expression

fullerene C60 results in decreased expression of CEBPD mRNA

NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829

G

CUGBP, Elav-like family member 5

decreases expression

fullerene C60 results in decreased expression of CELF5 mRNA

NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322

G

cell migration inducing hyaluronidase 2

affects expression

fullerene C60 affects the expression of CEMIP2 mRNA

NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760

G

centrosomal protein 164

decreases expression

fullerene C60 results in decreased expression of CEP164 mRNA

NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336

G

centrosomal protein 89

increases expression

fullerene C60 results in increased expression of CEP89 mRNA

NCBI chr 1:88,058,211...88,100,114
Ensembl chr 1:88,058,227...88,100,112

G

carboxylesterase 1C

decreases expression

fullerene C60 results in decreased expression of ES2 mRNA

NCBI chr19:13,926,401...13,955,527
Ensembl chr19:13,926,260...13,955,524

G

cilia and flagella associated protein 126

decreases expression

fullerene C60 results in decreased expression of CFAP126 mRNA

NCBI chr13:83,526,657...83,542,552
Ensembl chr13:83,526,657...83,542,552

G

cilia and flagella associated protein 210

increases expression

fullerene C60 results in increased expression of CFAP210 mRNA

NCBI chr 3:54,520,455...54,554,677
Ensembl chr 3:54,520,458...54,554,607

G

chondroadherin

decreases expression

fullerene C60 results in decreased expression of CHAD mRNA

NCBI chr10:79,512,170...79,515,941
Ensembl chr10:79,511,931...79,515,940

G

chromatin accessibility complex subunit 1

decreases expression

fullerene C60 results in decreased expression of CHRAC1 mRNA

NCBI chr 7:105,013,047...105,016,435
Ensembl chr 7:105,013,015...105,017,136

G

cholinergic receptor, muscarinic 1

decreases expression

fullerene C60 results in decreased expression of CHRM1 mRNA

NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356

G

cholinergic receptor, muscarinic 4

decreases expression

fullerene C60 results in decreased expression of CHRM4 mRNA

NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159

G

cholinergic receptor nicotinic gamma subunit

decreases expression

fullerene C60 results in decreased expression of CHRNG mRNA

NCBI chr 9:87,878,085...87,884,193
Ensembl chr 9:87,878,085...87,914,482

G

carbohydrate sulfotransferase 1

increases expression

fullerene C60 results in increased expression of CHST1 mRNA

NCBI chr 3:78,552,059...78,574,740
Ensembl chr 3:78,548,525...78,574,883

G

carbohydrate sulfotransferase 15

increases expression

fullerene C60 results in increased expression of CHST15 mRNA

NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:187,028,970...187,107,707

G

carbohydrate sulfotransferase 2

increases expression

fullerene C60 results in increased expression of CHST2 mRNA

NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955

G

citron rho-interacting serine/threonine kinase

decreases expression

fullerene C60 results in decreased expression of CIT mRNA

NCBI chr12:40,603,073...40,764,846
Ensembl chr12:40,605,563...40,763,860

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

fullerene C60 results in increased expression of CITED2 mRNA

NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897

G

chemokine-like factor

increases expression

fullerene C60 results in increased expression of CKLF mRNA

NCBI chr19:698,097...706,570
Ensembl chr19:698,033...706,570

G

creatine kinase, M-type

affects expression

fullerene C60 affects the expression of CKM mRNA

NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720

G

cardiotrophin-like cytokine factor 1

increases expression

fullerene C60 results in increased expression of CLCF1 mRNA

NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605

G

claudin 12

decreases expression

fullerene C60 results in decreased expression of CLDN12 mRNA

NCBI chr 4:28,522,659...28,533,647
Ensembl chr 4:28,522,678...28,533,801

G

claudin 15

decreases expression

fullerene C60 results in decreased expression of CLDN15 mRNA

NCBI chr12:19,698,167...19,708,419
Ensembl chr12:19,698,337...19,706,819

G

claudin 23

decreases expression

fullerene C60 results in decreased expression of CLDN23 mRNA

NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523

G

claudin 8

decreases expression

fullerene C60 results in decreased expression of CLDN8 mRNA

NCBI chr11:27,875,857...27,878,106
Ensembl chr11:27,875,692...27,878,513

G

claudin 9

increases expression

fullerene C60 results in increased expression of CLDN9 mRNA

NCBI chr10:12,714,137...12,715,568

G

C-type lectin domain family 4, member A1

increases expression

fullerene C60 results in increased expression of CLEC4A1 mRNA

NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008

G

CAP-GLY domain containing linker protein 3

increases expression

fullerene C60 results in increased expression of CLIP3 mRNA

NCBI chr 1:85,547,170...85,563,187
Ensembl chr 1:85,547,206...85,563,184

G

CLPTM1 regulator of GABA type A receptor forward trafficking

increases expression

fullerene C60 results in increased expression of CLPTM1 mRNA

NCBI chr 1:79,289,478...79,321,079
Ensembl chr 1:79,289,477...79,321,092

G

clavesin 1

decreases expression

fullerene C60 results in decreased expression of CLVS1 mRNA

NCBI chr 5:22,408,384...22,604,281
Ensembl chr 5:22,408,384...22,604,270

G

cyclic nucleotide gated channel subunit beta 1

decreases expression

fullerene C60 results in decreased expression of CNGB1 mRNA

NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173

G

cornichon family member 1

decreases expression

fullerene C60 results in decreased expression of CNIH1 mRNA

NCBI chr15:20,037,885...20,049,857
Ensembl chr15:20,037,885...20,049,761

G

calponin 1

increases expression

fullerene C60 results in increased expression of CNN1 mRNA

NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098

G

CCR4-NOT transcription complex, subunit 4

increases expression

fullerene C60 results in increased expression of CNOT4 mRNA

NCBI chr 4:63,712,770...63,814,355
Ensembl chr 4:63,712,770...63,814,360

G

2',3'-cyclic nucleotide 3' phosphodiesterase

decreases expression

fullerene C60 results in decreased expression of CNP mRNA

NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720

G

cyclin Pas1/PHO80 domain containing 1

decreases expression

fullerene C60 results in decreased expression of CNPPD1 mRNA

NCBI chr 9:76,633,475...76,640,164
Ensembl chr 9:76,633,477...76,640,188

G

canopy FGF signaling regulator 3

increases expression

fullerene C60 results in increased expression of CNPY3 mRNA

NCBI chr 9:14,233,478...14,247,847
Ensembl chr 9:14,233,428...14,247,831

G

cytochrome C oxidase assembly factor 3

decreases expression

fullerene C60 results in decreased expression of COA3 mRNA

NCBI chr10:86,220,192...86,221,173
Ensembl chr10:86,220,194...86,221,178

G

cochlin

increases expression

fullerene C60 results in increased expression of COCH mRNA

NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109

G

collagen type X alpha 1 chain

decreases expression

fullerene C60 results in decreased expression of COL10A1 mRNA

NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494

G

collagen type XX alpha 1 chain

decreases expression

fullerene C60 results in decreased expression of COL20A1 mRNA

NCBI chr 3:168,102,475...168,134,759
Ensembl chr 3:168,084,560...168,135,309

G

collagen type XXIII alpha 1 chain

increases expression

fullerene C60 results in increased expression of COL23A1 mRNA

NCBI chr10:35,549,090...35,839,152
Ensembl chr10:35,549,113...35,836,314

G

collagen type II alpha 1 chain

decreases expression

fullerene C60 results in decreased expression of COL2A1 mRNA

NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546

G

collagen type IV alpha 2 chain

increases expression

fullerene C60 results in increased expression of COL4A2 mRNA

NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839

G

collagen type V alpha 1 chain

increases expression

fullerene C60 results in increased expression of COL5A1 mRNA

NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588

G

collagen type VII alpha 1 chain

increases expression

fullerene C60 results in increased expression of COL7A1 mRNA

NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252

G

collagen type VIII alpha 1 chain

decreases expression

fullerene C60 results in decreased expression of COL8A1 mRNA

NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424

G

catechol-O-methyltransferase domain containing 1

decreases expression

fullerene C60 results in decreased expression of COMTD1 mRNA

NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895

G

COP9 signalosome subunit 5

decreases expression

fullerene C60 results in decreased expression of COPS5 mRNA

NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731

G

COPI coat complex subunit zeta 1

decreases expression

fullerene C60 results in decreased expression of COPZ1 mRNA

NCBI chr 7:134,409,523...134,435,661
Ensembl chr 7:134,409,799...134,435,662

G

coenzyme Q8A

decreases expression

fullerene C60 results in decreased expression of COQ8A mRNA

NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431

G

coronin 1A

decreases expression

fullerene C60 results in decreased expression of CORO1A mRNA

NCBI chr 1:181,295,561...181,300,566
Ensembl chr 1:181,295,562...181,300,534

G

cytochrome c oxidase subunit 6A2

decreases expression

fullerene C60 results in decreased expression of COX6A2 mRNA

NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274

G

carboxypeptidase A2

decreases expression

fullerene C60 results in decreased expression of CPA2 mRNA

NCBI chr 4:59,160,357...59,183,677
Ensembl chr 4:59,160,357...59,183,674

G

cytoplasmic polyadenylation element binding protein 1

decreases expression

fullerene C60 results in decreased expression of CPEB1 mRNA

NCBI chr 1:135,300,048...135,407,688
Ensembl chr 1:135,300,461...135,409,760

G

complexin 2

decreases expression

fullerene C60 results in decreased expression of CPLX2 mRNA

NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855

G

carnitine O-acetyltransferase

increases expression

fullerene C60 results in increased expression of CRAT mRNA

NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255

G

CREB binding protein

decreases expression

fullerene C60 results in decreased expression of CREBBP mRNA

NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888

G

cytokine receptor-like factor 1

increases expression

fullerene C60 results in increased expression of CRLF1 mRNA

NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997

G

CREB regulated transcription coactivator 2

decreases expression

fullerene C60 results in decreased expression of CRTC2 mRNA

NCBI chr 2:175,709,603...175,719,768
Ensembl chr 2:175,709,644...175,719,763

G

cryptochrome circadian regulator 2

increases expression

fullerene C60 results in increased expression of CRY2 mRNA

NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965

G

crystallin, beta B1

decreases expression

fullerene C60 results in decreased expression of CRYBB1 mRNA

NCBI chr12:44,369,734...44,383,344
Ensembl chr12:44,369,735...44,383,344

G

crystallin, mu

decreases expression

fullerene C60 results in decreased expression of CRYM mRNA

NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633

G

cold shock domain containing E1

decreases expression

fullerene C60 results in decreased expression of UNR mRNA

NCBI chr 2:190,546,015...190,582,787
Ensembl chr 2:190,554,980...190,582,784

G

colony stimulating factor 1 receptor

decreases expression

fullerene C60 results in decreased expression of CSF1R mRNA

NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415

G

colony stimulating factor 2 receptor subunit beta

decreases expression

fullerene C60 results in decreased expression of CSF2RB mRNA

NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157

G

casein kinase 1, gamma 2

increases expression

fullerene C60 results in increased expression of CSNK1G2 mRNA

NCBI chr 7:9,076,739...9,095,082
Ensembl chr 7:9,076,740...9,095,052

G

casein kinase 2 alpha 2

decreases expression

fullerene C60 results in decreased expression of CSNK2A2 mRNA

NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080

G

cleavage stimulation factor subunit 1

decreases expression

fullerene C60 results in decreased expression of CSTF1 mRNA

NCBI chr 3:161,144,522...161,156,294
Ensembl chr 3:161,144,548...161,156,300

G

cleavage stimulation factor subunit 2, tau variant

decreases expression

fullerene C60 results in decreased expression of CSTF2T mRNA

NCBI chr 1:228,952,617...228,956,183
Ensembl chr 1:228,952,504...228,955,873

G

CTD nuclear envelope phosphatase 1

increases expression

fullerene C60 results in increased expression of CTDNEP1 mRNA

NCBI chr10:54,704,367...54,713,781
Ensembl chr10:54,704,148...54,713,781

G

catenin beta 1

increases expression

fullerene C60 results in increased expression of CTNNB1 mRNA

NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111

G

chymotrypsinogen B1

decreases expression

fullerene C60 results in decreased expression of CTRB mRNA

NCBI chr19:39,652,931...39,657,689
Ensembl chr19:39,652,933...39,657,688

G

cathepsin 7 like 2

increases expression

fullerene C60 results in increased expression of CTS7L2 mRNA

NCBI chr17:3,903,602...3,907,088
Ensembl chr17:3,903,602...3,906,568

G

cathepsin K

increases expression

fullerene C60 results in increased expression of CTSK mRNA

NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550

G

cortexin 1

decreases expression

fullerene C60 results in decreased expression of CTXN1 mRNA

NCBI chr12:2,610,465...2,612,076

G

CUE domain containing 1

increases expression

fullerene C60 results in increased expression of CUEDC1 mRNA

NCBI chr10:72,892,637...72,986,546
Ensembl chr10:72,892,637...72,986,542

G

C-X-C motif chemokine ligand 1

increases expression

fullerene C60 results in increased expression of CXCL1 mRNA

NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215

G

C-X-C motif chemokine ligand 2

increases expression

fullerene C60 results in increased expression of CXCL2 mRNA

NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075

G

C-X-C motif chemokine ligand 3

increases expression

fullerene C60 results in increased expression of CXCL3 mRNA

NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511

G

cytochrome b5 domain containing 1

decreases expression

fullerene C60 results in decreased expression of CYB5D1 mRNA

NCBI chr10:54,113,428...54,117,744
Ensembl chr10:54,113,438...54,117,911

G

cytochrome b5 reductase 3

increases expression

fullerene C60 results in increased expression of CYB5R3 mRNA

NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298

G

cytochrome b-245 alpha chain

decreases expression

fullerene C60 results in decreased expression of CYBA mRNA

NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721

G

cytochrome P450, family 11, subfamily b, polypeptide 3

decreases expression

fullerene C60 results in decreased expression of CYP11B3 mRNA

NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048

G

cytochrome P450, family 17, subfamily a, polypeptide 1

decreases expression

fullerene C60 results in decreased expression of CYP17A1 mRNA

NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573

G

cytochrome P450, family 1, subfamily a, polypeptide 2

decreases expression

fullerene C60 results in decreased expression of CYP1A2 mRNA

NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 1, subfamily b, polypeptide 1

decreases expression

fullerene C60 results in decreased expression of CYP1B1 mRNA

NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917

G

cytochrome P450, family 26, subfamily b, polypeptide 1

decreases expression

fullerene C60 results in decreased expression of CYP26B1 mRNA

NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628

G

cytochrome P450, family 27, subfamily a, polypeptide 1

decreases expression

fullerene C60 results in decreased expression of CYP27A1 mRNA

NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551

G

cytochrome P450, family 2, subfamily a, polypeptide 3

increases expression

fullerene C60 results in increased expression of CYP2A3 mRNA

NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979

G

cytochrome P450, family 2, subfamily b, polypeptide 15

increases expression

fullerene C60 results in increased expression of CYP2B15 mRNA

NCBI chr 1:82,094,188...82,106,492
Ensembl chr 1:82,094,180...82,106,492

G

cytochrome P450, family 2, subfamily b, polypeptide 2

increases expression

fullerene C60 results in increased expression of CYP2B13 mRNA

NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566

G

cytochrome P450, family 2, subfamily b, polypeptide 3

increases expression

fullerene C60 results in increased expression of CYP2B3 mRNA

NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143

G

cytochrome P450, family 2, subfamily e, polypeptide 1

increases expression

fullerene C60 results in increased expression of CYP2E1 mRNA

NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023

G

cytochrome P450, family 2, subfamily u, polypeptide 1

increases expression

fullerene C60 results in increased expression of CYP2U1 mRNA

NCBI chr 2:219,849,403...219,866,959
Ensembl chr 2:219,849,407...219,866,882

G

CYFIP related Rac1 interactor B

decreases expression

fullerene C60 results in decreased expression of CYRIB mRNA

NCBI chr 7:95,633,876...95,760,588
Ensembl chr 7:95,633,876...95,697,686

G

cytokine like 1

affects expression

fullerene C60 affects the expression of CYTL1 mRNA

NCBI chr14:73,053,876...73,058,886
Ensembl chr14:73,053,877...73,058,886

G

cysteine and tyrosine rich 1

decreases expression

fullerene C60 results in decreased expression of CYYR1 mRNA

NCBI chr11:24,557,620...24,664,007
Ensembl chr11:24,515,316...24,663,961

G

D-2-hydroxyglutarate dehydrogenase

decreases expression

fullerene C60 results in decreased expression of D2HGDH mRNA

NCBI chr 9:94,350,555...94,368,384
Ensembl chr 9:94,350,576...94,368,382

G

dishevelled-binding antagonist of beta-catenin 2

increases expression

fullerene C60 results in increased expression of DACT2 mRNA

NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096

G

diacylglycerol lipase, alpha

decreases expression

fullerene C60 results in decreased expression of DAGLA mRNA

NCBI chr 1:206,890,635...206,947,332
Ensembl chr 1:206,890,638...206,947,232

G

dopamine beta-hydroxylase

decreases expression

fullerene C60 results in decreased expression of DBH mRNA

NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248

G

dysbindin domain containing 2

affects expression

fullerene C60 affects the expression of DBNDD2 mRNA

NCBI chr 3:153,216,300...153,220,651
Ensembl chr 3:153,191,090...153,220,651

G

D-box binding PAR bZIP transcription factor

increases expression

fullerene C60 results in increased expression of DBP mRNA

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745

G

DDB1 and CUL4 associated factor 1

decreases expression

fullerene C60 results in decreased expression of DCAF1 mRNA

NCBI chr 8:107,466,229...107,540,633
Ensembl chr 8:107,474,312...107,540,627

G

DDB1 and CUL4 associated factor 15

decreases expression

fullerene C60 results in decreased expression of DCAF15 mRNA

NCBI chr19:24,053,925...24,061,277
Ensembl chr19:24,053,925...24,061,277

G

DDB1 and CUL4 associated factor 6

decreases expression

fullerene C60 results in decreased expression of DCAF6 mRNA

NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512

G

doublecortin-like kinase 1

decreases expression

fullerene C60 results in decreased expression of DCLK1 mRNA

NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956

G

DC-STAMP domain containing 1

decreases expression

fullerene C60 results in decreased expression of DCST1 mRNA

NCBI chr 2:174,765,203...174,784,023
Ensembl chr 2:174,765,350...174,781,806

G

dynactin subunit 1

increases expression

fullerene C60 results in increased expression of DCTN1 mRNA

NCBI chr 4:115,671,024...115,703,824
Ensembl chr 4:115,661,638...115,703,815

G

DNA-damage-inducible transcript 4

decreases expression

fullerene C60 results in decreased expression of DDIT4 mRNA

NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105

G

DEAD-box helicase 1

decreases expression

fullerene C60 results in decreased expression of DDX1 mRNA

NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365

G

DEAD/H-box helicase 11

increases expression

fullerene C60 results in increased expression of DDX11 mRNA

NCBI chr 9:105,833,234...105,862,844
Ensembl chr 9:105,833,504...105,862,550

G

DEAD-box helicase 23

increases expression

fullerene C60 results in increased expression of DDX23 mRNA

NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949

G

DEAD-box helicase 24

decreases expression

fullerene C60 results in decreased expression of DDX24 mRNA

NCBI chr 6:122,564,767...122,582,032
Ensembl chr 6:122,564,767...122,581,927

G

DEAD-box helicase 3, X-linked

decreases expression

fullerene C60 results in decreased expression of DDX3X mRNA

NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168

G

differentially expressed in FDCP 8 homolog

decreases expression

fullerene C60 results in decreased expression of DEF8 mRNA

NCBI chr19:51,474,783...51,495,638
Ensembl chr19:51,474,878...51,495,638

G

defensin beta 22

decreases expression

fullerene C60 results in decreased expression of DEFB22 mRNA

NCBI chr 3:140,957,093...140,961,373
Ensembl chr 3:140,957,090...140,961,373

G

DEK proto-oncogene

decreases expression

fullerene C60 results in decreased expression of DEK mRNA

NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808

G

DENN domain containing 3

increases expression

fullerene C60 results in increased expression of DENND3 mRNA

NCBI chr 7:105,415,870...105,473,583
Ensembl chr 7:105,415,677...105,473,592

G

diacylglycerol kinase, beta

decreases expression

fullerene C60 results in decreased expression of DGKB mRNA

NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:54,641,614...55,397,043

G

dehydrodolichyl diphosphate synthase subunit

decreases expression

fullerene C60 results in decreased expression of DHDDS mRNA

NCBI chr 5:146,198,359...146,224,479
Ensembl chr 5:146,197,457...146,224,454

G

DEAH-box helicase 16

affects expression

fullerene C60 affects the expression of DHX16 mRNA

NCBI chr20:2,862,000...2,874,991
Ensembl chr20:2,862,000...2,874,948

G

DEAH-box helicase 36

increases expression

fullerene C60 results in increased expression of DHX36 mRNA

NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572

G

iodothyronine deiodinase 3

decreases expression

fullerene C60 results in decreased expression of DIO3 mRNA

NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660

G

dyskerin pseudouridine synthase 1

decreases expression

fullerene C60 results in decreased expression of DKC1 mRNA

G

delta like non-canonical Notch ligand 2

increases expression

fullerene C60 results in increased expression of DLK2 mRNA

NCBI chr 9:14,677,102...14,681,584
Ensembl chr 9:14,676,562...14,681,594

G

delta like canonical Notch ligand 1

decreases expression

fullerene C60 results in decreased expression of DLL1 mRNA

NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179

G

distal-less homeobox 2

decreases expression

fullerene C60 results in decreased expression of DLX2 mRNA

NCBI chr 3:56,370,238...56,373,581
Ensembl chr 3:56,370,483...56,373,597

G

distal-less homeobox 5

increases expression

fullerene C60 results in increased expression of DLX5 mRNA

NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407

G

DMRT-like family A2

increases expression

fullerene C60 results in increased expression of DMRTA2 mRNA

NCBI chr 5:124,805,883...124,811,694
Ensembl chr 5:124,805,883...124,811,630

G

dematin actin binding protein

increases expression

fullerene C60 results in increased expression of DMTN mRNA

NCBI chr15:45,677,974...45,702,261
Ensembl chr15:45,677,977...45,705,601

G

dynein, axonemal, assembly factor 1

decreases expression

fullerene C60 results in decreased expression of DNAAF1 mRNA

NCBI chr19:47,624,534...47,652,314
Ensembl chr19:47,624,181...47,652,313

G

dynein, axonemal, heavy chain 1

decreases expression

fullerene C60 results in decreased expression of DNAH1 mRNA

NCBI chr16:6,455,514...6,517,103
Ensembl chr16:6,456,002...6,518,350

G

dynein, axonemal, heavy chain 17

decreases expression

fullerene C60 results in decreased expression of DNAH17 mRNA

NCBI chr10:103,244,144...103,364,953
Ensembl chr10:103,249,363...103,364,901

G

DnaJ heat shock protein family (Hsp40) member B13

decreases expression

fullerene C60 results in decreased expression of DNAJB13 mRNA

NCBI chr 1:154,848,586...154,863,042
Ensembl chr 1:154,848,594...154,862,963

G

DnaJ heat shock protein family (Hsp40) member B5

affects expression

fullerene C60 affects the expression of DNAJB5 mRNA

NCBI chr 5:57,176,840...57,186,067
Ensembl chr 5:57,176,845...57,185,490

G

deoxyribonuclease 2 beta

decreases expression

fullerene C60 results in decreased expression of DNASE2B mRNA

NCBI chr 2:235,470,915...235,515,211
Ensembl chr 2:235,470,919...235,486,295

G

dynamin 1-like

decreases expression

fullerene C60 results in decreased expression of DNM1L mRNA

NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482

G

double C2 domain beta

decreases expression

fullerene C60 results in decreased expression of DOC2B mRNA

NCBI chr10:60,628,029...60,653,267
Ensembl chr10:60,628,029...60,653,267

G

dipeptidyl peptidase 9

increases expression

fullerene C60 results in increased expression of DPP9 mRNA

NCBI chr 9:1,011,347...1,046,337
Ensembl chr 9:1,011,351...1,046,541

G

dopamine receptor D2

decreases expression

fullerene C60 results in decreased expression of DRD2 mRNA

NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875

G

dopamine receptor D3

decreases expression

fullerene C60 results in decreased expression of DRD3 mRNA

NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596

G

dopamine receptor D5

decreases expression

fullerene C60 results in decreased expression of DRD5 mRNA

NCBI chr14:72,487,950...72,491,050
Ensembl chr14:72,489,347...72,490,774

G

DSN1 component of MIS12 kinetochore complex

increases expression

fullerene C60 results in increased expression of DSN1 mRNA

NCBI chr 3:145,652,741...145,668,025
Ensembl chr 3:145,652,737...145,665,856

G

dystrobrevin, beta

increases expression

fullerene C60 results in increased expression of DTNB mRNA

NCBI chr 6:26,566,418...26,763,467
Ensembl chr 6:26,566,925...26,766,335

G

dual specificity phosphatase 15

decreases expression

fullerene C60 results in decreased expression of DUSP15 mRNA

NCBI chr 3:141,408,495...141,419,137
Ensembl chr 3:141,408,498...141,418,999

G

dual specificity phosphatase 3

increases expression

fullerene C60 results in increased expression of DUSP3 mRNA

NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962

G

dual specificity phosphatase 7

decreases expression

fullerene C60 results in decreased expression of DUSP7 mRNA

NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404

G

dual specificity phosphatase 9

decreases expression

fullerene C60 results in decreased expression of DUSP9 mRNA

NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821

G

dual specificity tyrosine phosphorylation regulated kinase 2

increases expression

fullerene C60 results in increased expression of DYRK2 mRNA

NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106

G

EBP, cholestenol delta-isomerase

decreases expression

fullerene C60 results in decreased expression of EBP mRNA

NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826

G

enhancer of mRNA decapping 4

decreases expression

fullerene C60 results in decreased expression of EDC4 mRNA

NCBI chr19:33,774,062...33,786,054
Ensembl chr19:33,774,055...33,787,758

G

endothelin 3

affects expression

fullerene C60 affects the expression of EDN3 mRNA

NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093

G

eukaryotic translation elongation factor 1 alpha 2

affects expression

fullerene C60 affects the expression of EEF1A2 mRNA

NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071

G

eukaryotic translation elongation factor 1 gamma

decreases expression

fullerene C60 results in decreased expression of EEF1G mRNA

NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382

G

eukaryotic elongation factor-2 kinase

increases expression

fullerene C60 results in increased expression of EEF2K mRNA

NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164

G

EEIG family member 2

decreases expression

fullerene C60 results in decreased expression of EEIG2 mRNA

NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371

G

endonuclease/exonuclease/phosphatase family domain containing 1

increases expression

fullerene C60 results in increased expression of EEPD1 mRNA

NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340

G

EF-hand calcium binding domain 11

decreases expression

fullerene C60 results in decreased expression of EFCAB11 mRNA

NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046

G

EF-hand domain family, member D2

decreases expression

fullerene C60 results in decreased expression of EFHD2 mRNA

NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980

G

ephrin A3

decreases expression

fullerene C60 results in decreased expression of EFNA3 mRNA

NCBI chr 2:174,729,192...174,738,111
Ensembl chr 2:174,729,764...174,738,736

G

ephrin B3

decreases expression

fullerene C60 results in decreased expression of EFNB3 mRNA

NCBI chr10:54,274,506...54,281,951
Ensembl chr10:54,274,506...54,280,471

G

egl-9 family hypoxia-inducible factor 2

increases expression

fullerene C60 results in increased expression of EGLN2 mRNA

NCBI chr 1:82,451,554...82,459,809
Ensembl chr 1:82,451,555...82,459,751

G

EH domain binding protein 1-like 1

increases expression

fullerene C60 results in increased expression of EHBP1L1 mRNA

NCBI chr 1:202,994,115...203,014,320
Ensembl chr 1:202,994,118...203,014,270

G

EH-domain containing 1

decreases expression

fullerene C60 results in decreased expression of EHD1 mRNA

NCBI chr 1:203,579,850...203,602,226
Ensembl chr 1:203,579,869...203,602,212

G

EH-domain containing 3

increases expression

fullerene C60 results in increased expression of EHD3 mRNA

NCBI chr 6:21,640,861...21,665,601
Ensembl chr 6:21,639,290...21,665,236

G

euchromatic histone lysine methyltransferase 2

increases expression

fullerene C60 results in increased expression of EHMT2 mRNA

NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547

G

eukaryotic translation initiation factor 3, subunit B

increases expression

fullerene C60 results in increased expression of EIF3B mRNA

NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886

G

eukaryotic translation initiation factor 6

decreases expression

fullerene C60 results in decreased expression of EIF6 mRNA

NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401

G

E74 like ETS transcription factor 1

decreases expression

fullerene C60 results in decreased expression of ELF1 mRNA

NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699

G

elastin

decreases expression

fullerene C60 results in decreased expression of ELN mRNA

NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928

G

ELOVL fatty acid elongase 5

decreases expression

fullerene C60 results in decreased expression of ELOVL5 mRNA

NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284

G

EMAP like 1

decreases expression

fullerene C60 results in decreased expression of EML1 mRNA

NCBI chr 6:127,283,968...127,457,246
Ensembl chr 6:127,284,029...127,457,246

G

endoglin

increases expression

fullerene C60 results in increased expression of ENG mRNA

NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230

G

endo-beta-N-acetylglucosaminidase

decreases expression

fullerene C60 results in decreased expression of ENGASE mRNA

NCBI chr10:103,707,169...103,719,833
Ensembl chr10:103,707,169...103,719,819

G

endosome associated trafficking regulator 1

decreases expression

fullerene C60 results in decreased expression of ENTR1 mRNA

NCBI chr 3:9,200,967...9,207,688
Ensembl chr 3:9,200,967...9,207,688

G

endosomal transmembrane epsin interactor 1

increases expression

fullerene C60 results in increased expression of ENTREP1 mRNA

NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758

G

Eph receptor A4

decreases expression

fullerene C60 results in decreased expression of EPHA4 mRNA

NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139

G

Eph receptor A8

decreases expression

fullerene C60 results in decreased expression of EPHA8 mRNA

NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:149,166,697...149,193,399

G

Eph receptor B2

decreases expression

fullerene C60 results in decreased expression of EPHB2 mRNA

NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059

G

Eph receptor B3

increases expression

fullerene C60 results in increased expression of EPHB3 mRNA

NCBI chr11:79,840,668...79,859,345
Ensembl chr11:79,840,668...79,859,370

G

epoxide hydrolase 3

decreases expression

fullerene C60 results in decreased expression of EPHX3 mRNA

NCBI chr 7:11,206,812...11,212,122
Ensembl chr 7:11,206,812...11,212,122

G

epsin 2

increases expression

fullerene C60 results in increased expression of EPN2 mRNA

NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642

G

erythropoietin receptor

decreases expression

fullerene C60 results in decreased expression of EPOR mRNA

NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257

G

ERCC excision repair 4, endonuclease catalytic subunit

increases expression

fullerene C60 results in increased expression of ERCC4 mRNA

NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369

G

ERCC excision repair 5, endonuclease

decreases expression

fullerene C60 results in decreased expression of ERCC5 mRNA

NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472

G

ERGIC and golgi 2

affects expression

fullerene C60 affects the expression of ERGIC2 mRNA

NCBI chr 4:181,090,808...181,123,074
Ensembl chr 4:181,090,808...181,123,060

G

ERBB receptor feedback inhibitor 1

decreases expression

fullerene C60 results in decreased expression of ERRFI1 mRNA

NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282

G

espin

decreases expression

fullerene C60 results in decreased expression of ESPN mRNA

NCBI chr 5:162,626,560...162,660,439
Ensembl chr 5:162,626,560...162,660,256

G

ess-2 splicing factor homolog

increases expression

fullerene C60 results in increased expression of ESS2 mRNA

NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846

G

ethanolamine kinase 1

decreases expression

fullerene C60 results in decreased expression of ETNK1 mRNA

NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770

G

ETS variant transcription factor 3

decreases expression

fullerene C60 results in decreased expression of ETV3 mRNA

NCBI chr 2:172,965,461...172,980,320
Ensembl chr 2:172,965,588...172,980,314

G

ETS variant transcription factor 4

increases expression

fullerene C60 results in increased expression of ETV4 mRNA

NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974

G

ETS variant transcription factor 5

increases expression

fullerene C60 results in increased expression of ETV5 mRNA

NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215

G

eva-1 homolog B

decreases expression

fullerene C60 results in decreased expression of EVA1B mRNA

NCBI chr 5:138,427,088...138,429,602
Ensembl chr 5:138,427,151...138,432,433

G

exocyst complex component 3-like 1

increases expression

fullerene C60 results in increased expression of EXOC3L1 mRNA

NCBI chr19:33,166,836...33,174,371
Ensembl chr19:33,166,837...33,172,486

G

exosome component 8

decreases expression

fullerene C60 results in decreased expression of EXOSC8 mRNA

NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928

G

exophilin 5

decreases expression

fullerene C60 results in decreased expression of EXPH5 mRNA

NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169

G

EYA transcriptional coactivator and phosphatase 4

decreases expression

fullerene C60 results in decreased expression of EYA4 mRNA

NCBI chr 1:22,172,275...22,415,978
Ensembl chr 1:22,172,275...22,415,976

G

coagulation factor X

decreases expression

fullerene C60 results in decreased expression of F10 mRNA

NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141

G

coagulation factor XII

decreases expression

fullerene C60 results in decreased expression of F12 mRNA

NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530

G

coagulation factor II (thrombin) receptor

decreases expression

fullerene C60 results in decreased expression of F2R mRNA

NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870

G

F2R like trypsin receptor 1

decreases expression

fullerene C60 results in decreased expression of F2RL1 mRNA

NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226

G

coagulation factor II (thrombin) receptor-like 2

decreases expression

fullerene C60 results in decreased expression of F2RL2 mRNA

NCBI chr 2:26,972,054...26,977,098
Ensembl chr 2:26,972,054...26,977,098

G

F2R like thrombin or trypsin receptor 3

decreases expression

fullerene C60 results in decreased expression of F2RL3 mRNA

NCBI chr16:17,117,441...17,119,434
Ensembl chr16:17,117,441...17,119,472

G

Fas apoptotic inhibitory molecule 2

decreases expression

fullerene C60 results in decreased expression of FAIM2 mRNA

NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168

G

family with sequence similarity 120 member B

decreases expression

fullerene C60 results in decreased expression of FAM120B mRNA

NCBI chr 1:56,320,015...56,385,064
Ensembl chr 1:56,339,129...56,385,061

G

family with sequence similarity 13, member B

increases expression

fullerene C60 results in increased expression of FAM13B mRNA

NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587

G

family with sequence similarity 151, member A

decreases expression

fullerene C60 results in decreased expression of FAM151A mRNA

NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:121,514,804...121,527,555

G

family with sequence similarity 168, member A

decreases expression

fullerene C60 results in decreased expression of FAM168A mRNA

NCBI chr 1:155,057,352...155,203,439
Ensembl chr 1:155,057,352...155,201,220

G

FAM20B, glycosaminoglycan xylosylkinase

decreases expression

fullerene C60 results in decreased expression of FAM20B mRNA

NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915

G

family with sequence similarity 234, member A

increases expression

fullerene C60 results in increased expression of FAM234A mRNA

NCBI chr10:15,232,267...15,263,529
Ensembl chr10:15,232,278...15,263,488

G

family with sequence similarity 98, member C

decreases expression

fullerene C60 results in decreased expression of FAM98C mRNA

NCBI chr 1:84,452,806...84,456,414
Ensembl chr 1:84,452,814...84,456,385

G

FERM, ARH/RhoGEF and pleckstrin domain protein 1

increases expression

fullerene C60 results in increased expression of FARP1 mRNA

NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299

G

fibrillarin-like 1

decreases expression

fullerene C60 results in decreased expression of FBLL1 mRNA

NCBI chr10:20,258,656...20,260,299
Ensembl chr10:20,258,656...20,260,299

G

fibrillin 2

decreases expression

fullerene C60 results in decreased expression of FBN2 mRNA

NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976

G

F-box and leucine-rich repeat protein 13

decreases expression

fullerene C60 results in decreased expression of FBXL13 mRNA

NCBI chr 4:13,414,880...13,607,079
Ensembl chr 4:13,414,926...13,641,494

G

F-box and leucine-rich repeat protein 2

decreases expression

fullerene C60 results in decreased expression of FBXL2 mRNA

NCBI chr 8:113,916,660...113,965,137
Ensembl chr 8:113,913,373...113,965,066

G

F-box protein 2

decreases expression

fullerene C60 results in decreased expression of FBXO2 mRNA

NCBI chr 5:158,592,926...158,598,355
Ensembl chr 5:158,592,925...158,598,355

G

F-box protein 39

increases expression

fullerene C60 results in increased expression of FBXO39 mRNA

NCBI chr10:56,929,699...56,934,911
Ensembl chr10:56,932,297...56,934,906

G

F-box and WD repeat domain containing 5

increases expression

fullerene C60 results in increased expression of FBXW5 mRNA

NCBI chr 3:8,322,543...8,327,092
Ensembl chr 3:8,322,543...8,327,092

G

Fcf1 rRNA-processing protein

increases expression

fullerene C60 results in increased expression of NOMO1 mRNA

NCBI chr 6:104,617,780...104,629,643
Ensembl chr 6:104,617,770...104,629,643

G

ficolin B

increases expression

fullerene C60 results in increased expression of FCNB mRNA

NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151

G

FES proto-oncogene, tyrosine kinase

increases expression

fullerene C60 results in increased expression of FES mRNA

NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934

G

FYVE, RhoGEF and PH domain containing 2

increases expression

fullerene C60 results in increased expression of FGD2 mRNA

NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,424,790...7,441,603

G

fibroblast growth factor 2

decreases expression

fullerene C60 results in decreased expression of FGF2 mRNA

NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221

G

fibroblast growth factor receptor 4

increases expression

fullerene C60 results in increased expression of FGFR4 mRNA

NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242

G

fibrinogen-like 2

decreases expression

fullerene C60 results in decreased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207

G

fumarate hydratase

decreases expression

fullerene C60 results in decreased expression of FH mRNA

NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266

G

FHF complex subunit HOOK interacting protein 2B

increases expression

fullerene C60 results in increased expression of FHIP2B mRNA

NCBI chr15:45,656,641...45,674,603
Ensembl chr15:45,656,647...45,674,105

G

formin homology 2 domain containing 1

decreases expression

fullerene C60 results in decreased expression of FHOD1 mRNA

NCBI chr19:33,206,492...33,225,448
Ensembl chr19:33,206,492...33,225,356

G

fin bud initiation factor homolog

decreases expression

fullerene C60 results in decreased expression of FIBIN mRNA

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

FKBP prolyl isomerase 4

increases expression

fullerene C60 results in increased expression of FKBP4 mRNA

NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833

G

FKBP prolyl isomerase 5

affects expression

fullerene C60 affects the expression of FKBP5 mRNA

NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674

G

filaggrin

decreases expression

fullerene C60 results in decreased expression of FLG mRNA

NCBI chr 2:178,884,793...178,912,986

G

filamin B

increases expression

fullerene C60 results in increased expression of FLNB mRNA

NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006

G

Fms related receptor tyrosine kinase 1

decreases expression

fullerene C60 results in decreased expression of FLT1 mRNA

NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626

G

formin-like 1

increases expression

fullerene C60 results in increased expression of FMNL1 mRNA

NCBI chr10:88,115,876...88,143,342
Ensembl chr10:88,116,009...88,143,357

G

flavin containing dimethylaniline monoxygenase 3

increases expression

fullerene C60 results in increased expression of FMO3 mRNA

NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028

G

fibronectin type III domain containing 7

increases expression

fullerene C60 results in increased expression of FNDC7 mRNA

NCBI chr 2:196,501,313...196,537,816
Ensembl chr 2:196,502,460...196,537,694

G

fibronectin type III domain containing 8

decreases expression

fullerene C60 results in decreased expression of FNDC8 mRNA

NCBI chr10:67,825,952...67,834,090
Ensembl chr10:67,825,952...67,834,090

G

farnesyltransferase, CAAX box, subunit beta

increases expression

fullerene C60 results in increased expression of FNTB mRNA

NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586

G

folate receptor alpha

decreases expression

fullerene C60 results in decreased expression of FOLR1 mRNA

NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667

G

Fos proto-oncogene, AP-1 transcription factor subunit

increases expression

fullerene C60 results in increased expression of FOS mRNA

NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036

G

FOS like 1, AP-1 transcription factor subunit

decreases expression

fullerene C60 results in decreased expression of FOSL1 mRNA

NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930

G

FOS like 2, AP-1 transcription factor subunit

decreases expression

fullerene C60 results in decreased expression of FOSL2 mRNA

NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034

G

forkhead box B1

decreases expression

fullerene C60 results in decreased expression of FOXB1 mRNA

NCBI chr 8:70,407,221...70,409,841
Ensembl chr 8:70,408,186...70,409,781

G

forkhead box C2

decreases expression

fullerene C60 results in decreased expression of FOXC2 mRNA

NCBI chr19:49,186,034...49,188,736
Ensembl chr19:49,185,662...49,188,737

G

forkhead box N1

decreases expression

fullerene C60 results in decreased expression of FOXN1 mRNA

NCBI chr10:63,251,400...63,273,710
Ensembl chr10:63,251,400...63,273,710

G

forkhead box N4

decreases expression

fullerene C60 results in decreased expression of FOXN4 mRNA

NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921

G

forkhead box O3

decreases expression

fullerene C60 results in decreased expression of FOXO3 mRNA

NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561

G

FAD-dependent oxidoreductase domain containing 2

decreases expression

fullerene C60 results in decreased expression of FOXRED2 mRNA

NCBI chr 7:109,521,761...109,538,300
Ensembl chr 7:109,521,761...109,540,874

G

FRAS1 related extracellular matrix 2

decreases expression

fullerene C60 results in decreased expression of FREM2 mRNA

NCBI chr 2:137,602,784...137,740,785
Ensembl chr 2:137,602,784...137,740,785

G

FERM domain containing 4A

decreases expression

fullerene C60 results in decreased expression of FRMD4A mRNA

NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687

G

FERM domain containing 4B

decreases expression

fullerene C60 results in decreased expression of FRMD4B mRNA

NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197

G

follistatin like 3

increases expression

fullerene C60 results in increased expression of FSTL3 mRNA

NCBI chr 7:9,923,574...9,929,223
Ensembl chr 7:9,923,576...9,939,639

G

FMR1 autosomal homolog 2

increases expression

fullerene C60 results in increased expression of FXR2 mRNA

NCBI chr10:54,350,577...54,370,964
Ensembl chr10:54,350,131...54,370,964

G

frizzled class receptor 2

increases expression

fullerene C60 results in increased expression of FZD2 mRNA

NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334

G

GRB2-associated binding protein 2

decreases expression

fullerene C60 results in decreased expression of GAB2 mRNA

NCBI chr 1:151,429,844...151,625,708
Ensembl chr 1:151,429,695...151,625,031

G

gamma-aminobutyric acid type A receptor subunit theta

decreases expression

fullerene C60 results in decreased expression of GABRQ mRNA

NCBI chr X:150,696,161...150,712,948
Ensembl chr X:150,696,427...150,709,919

G

polypeptide N-acetylgalactosaminyltransferase 16

decreases expression

fullerene C60 results in decreased expression of GALNT16 mRNA

NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705

G

glyceraldehyde-3-phosphate dehydrogenase, spermatogenic

decreases expression

fullerene C60 results in decreased expression of GAPDHS mRNA

NCBI chr 1:85,979,096...85,994,153
Ensembl chr 1:85,979,098...85,993,640

G

golgi associated RAB2 interactor 1B

decreases expression

fullerene C60 results in decreased expression of GARIN1B mRNA

NCBI chr 4:57,915,184...57,938,593
Ensembl chr 4:57,920,790...57,938,591

G

growth arrest-specific 2

decreases expression

fullerene C60 results in decreased expression of GAS2 mRNA

NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619

G

growth arrest specific 7

increases expression

fullerene C60 results in increased expression of GAS7 mRNA

NCBI chr10:52,152,718...52,383,283
Ensembl chr10:52,152,493...52,383,276

G

gastrin

decreases expression

fullerene C60 results in decreased expression of GAST mRNA

NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496

G

GATA zinc finger domain containing 2A

increases expression

fullerene C60 results in increased expression of GATAD2A mRNA

NCBI chr16:19,429,578...19,520,320
Ensembl chr16:19,429,578...19,519,587

G

gastrulation brain homeobox 2

decreases expression

fullerene C60 results in decreased expression of GBX2 mRNA

NCBI chr 9:90,509,633...90,512,212
Ensembl chr 9:90,509,633...90,512,212

G

glutamate cysteine ligase, modifier subunit

decreases expression

fullerene C60 results in decreased expression of GCLM mRNA

NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535

G

guanine deaminase

increases expression

fullerene C60 results in increased expression of GDA mRNA

NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416

G

ganglioside-induced differentiation-associated-protein 1

decreases expression

fullerene C60 results in decreased expression of GDAP1 mRNA

NCBI chr 5:1,932,613...1,951,691
Ensembl chr 5:1,932,613...2,030,061

G

growth differentiation factor 15

decreases expression

fullerene C60 results in decreased expression of GDF15 mRNA

NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055

G

growth differentiation factor 5

decreases expression

fullerene C60 results in decreased expression of GDF5 mRNA

NCBI chr 3:144,454,316...144,458,508
Ensembl chr 3:144,454,338...144,458,612

G

growth differentiation factor 7

decreases expression

fullerene C60 results in decreased expression of GDF7 mRNA

NCBI chr 6:31,171,495...31,182,484
Ensembl chr 6:31,178,119...31,182,447

G

GH3 domain containing

decreases expression

fullerene C60 results in decreased expression of GHDC mRNA

NCBI chr10:85,693,612...85,697,833
Ensembl chr10:85,693,616...85,697,865

G

growth hormone releasing hormone

decreases expression

fullerene C60 results in decreased expression of GHRH mRNA

NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889

G

gonadotropin inducible ovarian transcription factor 1

increases expression

fullerene C60 results in increased expression of GIOT1 mRNA

NCBI chr 7:10,215,602...10,236,423
Ensembl chr 7:10,202,982...10,237,099

G

GIPC PDZ domain containing family, member 1

increases expression

fullerene C60 results in increased expression of GIPC1 mRNA

NCBI chr19:24,474,291...24,487,083
Ensembl chr19:24,453,123...24,486,997

G

GIPC PDZ domain containing family, member 2

increases expression

fullerene C60 results in increased expression of GIPC2 mRNA

NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236

G

gap junction protein, alpha 4

decreases expression

fullerene C60 results in decreased expression of GJA4 mRNA

NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925

G

gap junction protein, beta 1

decreases expression

fullerene C60 results in decreased expression of GJB1 mRNA

NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925

G

gap junction protein, beta 4

decreases expression

fullerene C60 results in decreased expression of GJB4 mRNA

NCBI chr 5:139,675,776...139,679,551
Ensembl chr 5:139,675,780...139,679,667

G

gap junction protein, beta 5

decreases expression

fullerene C60 results in decreased expression of GJB5 mRNA

NCBI chr 5:139,680,670...139,683,588
Ensembl chr 5:139,680,671...139,683,583

G

gap junction protein, delta 4

decreases expression

fullerene C60 results in decreased expression of GJD4 mRNA

NCBI chr17:57,348,844...57,352,601
Ensembl chr17:57,349,877...57,352,446

G

GLIS family zinc finger 2

increases expression

fullerene C60 results in increased expression of GLIS2 mRNA

NCBI chr10:10,951,157...10,978,524
Ensembl chr10:10,951,371...10,971,578

G

glomulin, FKBP associated protein

increases expression

fullerene C60 results in increased expression of GLMN mRNA

NCBI chr14:2,187,144...2,231,295
Ensembl chr14:2,187,642...2,230,420

G

glucagon-like peptide 1 receptor

increases expression

fullerene C60 results in increased expression of GLP1R mRNA

NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241

G

geminin, DNA replication inhibitor

increases expression

fullerene C60 results in increased expression of GMNN mRNA

NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054

G

G protein subunit alpha 12

increases expression

fullerene C60 results in increased expression of GNA12 mRNA

NCBI chr12:13,805,580...13,886,255
Ensembl chr12:13,805,698...13,886,255

G

G protein subunit alpha 15

increases expression

fullerene C60 results in increased expression of GNA15 mRNA

NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508

G

G protein subunit alpha L

decreases expression

fullerene C60 results in decreased expression of GNAL mRNA

NCBI chr18:60,622,311...60,762,599
Ensembl chr18:60,622,311...60,762,599

G

G protein subunit beta 2

increases expression

fullerene C60 results in increased expression of GNB2 mRNA

NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019

G

G protein subunit gamma 2

decreases expression

fullerene C60 results in decreased expression of GNG2 mRNA

NCBI chr15:4,316,038...4,416,918
Ensembl chr15:4,316,059...4,417,183

G

golgin A3

increases expression

fullerene C60 results in increased expression of GOLGA3 mRNA

NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509

G

golgi SNAP receptor complex member 1

decreases expression

fullerene C60 results in decreased expression of GOSR1 mRNA

NCBI chr10:61,570,499...61,607,287
Ensembl chr10:61,450,494...61,607,177
Ensembl chr10:61,450,494...61,607,177

G

golgi SNAP receptor complex member 2

decreases expression

fullerene C60 results in decreased expression of GOSR2 mRNA

NCBI chr10:88,585,291...88,605,642
Ensembl chr10:88,586,299...88,605,625

G

glutamic-oxaloacetic transaminase 2

increases expression

fullerene C60 results in increased expression of GOT2 mRNA

NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994

G

glycoprotein Ib platelet subunit beta

decreases expression

fullerene C60 results in decreased expression of GP1BB mRNA

NCBI chr11:82,378,216...82,379,393
Ensembl chr11:82,378,199...82,379,392

G

G patch domain containing 2

decreases expression

fullerene C60 results in decreased expression of GPATCH2 mRNA

NCBI chr13:98,784,993...98,925,696
Ensembl chr13:98,784,969...98,925,661

G

GC-rich promoter binding protein 1

increases expression

fullerene C60 results in increased expression of GPBP1 mRNA

NCBI chr 2:43,023,504...43,091,146
Ensembl chr 2:43,023,504...43,090,907

G

glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1

affects expression

fullerene C60 affects the expression of GPIHBP1 mRNA

NCBI chr 7:107,285,584...107,288,702
Ensembl chr 7:107,285,654...107,288,702

G

G protein-coupled receptor 146

increases expression

fullerene C60 results in increased expression of GPR146 mRNA

NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206

G

G protein-coupled receptor 15

decreases expression

fullerene C60 results in decreased expression of GPR15 mRNA

NCBI chr11:41,898,300...41,899,646
Ensembl chr11:41,898,356...41,900,441

G

G protein-coupled receptor 153

decreases expression

fullerene C60 results in decreased expression of GPR153 mRNA

NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971

G

G protein-coupled receptor 156

decreases expression

fullerene C60 results in decreased expression of GPR156 mRNA

NCBI chr11:62,722,632...62,815,402
Ensembl chr11:62,723,872...62,815,435

G

G protein-coupled receptor 157

increases expression

fullerene C60 results in increased expression of GPR157 mRNA

NCBI chr 5:160,550,703...160,566,432
Ensembl chr 5:160,550,713...160,566,432

G

G protein-coupled receptor 162

decreases expression

fullerene C60 results in decreased expression of GPR162 mRNA

NCBI chr 4:157,662,200...157,668,341
Ensembl chr 4:157,662,200...157,668,121

G

G protein-coupled receptor 22

decreases expression

fullerene C60 results in decreased expression of GPR22 mRNA

NCBI chr 6:48,309,619...48,317,864
Ensembl chr 6:48,310,505...48,317,486

G

G protein-coupled receptor 3

decreases expression

fullerene C60 results in decreased expression of GPR3 mRNA

NCBI chr 5:145,411,500...145,414,621
Ensembl chr 5:145,411,510...145,414,590

G

G protein-coupled receptor associated sorting protein family member 3

decreases expression

fullerene C60 results in decreased expression of GPRASP3 mRNA

NCBI chr X:98,847,591...98,854,949
Ensembl chr X:98,817,593...98,854,545

G

G protein-regulated inducer of neurite outgrowth 1

decreases expression

fullerene C60 results in decreased expression of GPRIN1 mRNA

NCBI chr17:9,863,881...9,876,832
Ensembl chr17:9,863,571...9,876,915

G

G-protein signaling modulator 1

decreases expression

fullerene C60 results in decreased expression of GPSM1 mRNA

NCBI chr 3:9,140,816...9,167,828
Ensembl chr 3:9,128,636...9,167,827

G

G-protein signaling modulator 3

decreases expression

fullerene C60 results in decreased expression of GPSM3 mRNA

NCBI chr20:4,157,123...4,158,984
Ensembl chr20:4,157,123...4,159,035

G

glutathione peroxidase 3

increases expression

fullerene C60 results in increased expression of GPX3 mRNA

NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035

G

glutathione peroxidase 6

decreases expression

fullerene C60 results in decreased expression of GPX6 mRNA

NCBI chr17:43,408,472...43,416,091
Ensembl chr17:43,408,472...43,416,091

G

growth factor receptor bound protein 10

decreases expression

fullerene C60 results in decreased expression of GRB10 mRNA

NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806

G

gremlin 1, DAN family BMP antagonist

decreases expression

fullerene C60 results in decreased expression of GREM1 mRNA

NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082

G

gremlin 2, DAN family BMP antagonist

decreases expression

fullerene C60 results in decreased expression of GREM2 mRNA

NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615

G

glutamate ionotropic receptor kainate type subunit 1

decreases expression

fullerene C60 results in decreased expression of GRIK1 mRNA

NCBI chr11:27,169,739...27,571,131
Ensembl chr11:27,169,740...27,570,645

G

glutamate ionotropic receptor NMDA type subunit 1

decreases expression

fullerene C60 results in decreased expression of GRIN1 mRNA

NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603

G

glutamate ionotropic receptor NMDA type subunit 2D

decreases expression

fullerene C60 results in decreased expression of GRIN2D mRNA

NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793

G

glutamate ionotropic receptor NMDA type subunit associated protein 1

increases expression

fullerene C60 results in increased expression of GRINA mRNA

NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366

G

G protein-coupled receptor kinase 1

decreases expression

fullerene C60 results in decreased expression of GRK1 mRNA

NCBI chr16:76,122,501...76,135,792
Ensembl chr16:76,123,842...76,135,792

G

G protein-coupled receptor kinase 6

decreases expression

fullerene C60 results in decreased expression of GRK6 mRNA

NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644

G

glutathione S-transferase mu 4

increases expression

fullerene C60 results in increased expression of GSTM4 mRNA

NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323

G

glutathione S-transferase, mu 5-like

decreases expression

fullerene C60 results in decreased expression of GSTM5 mRNA

NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961

G

GS homeobox 1

decreases expression

fullerene C60 results in decreased expression of GSX1 mRNA

NCBI chr12:7,880,663...7,882,947
Ensembl chr12:7,881,460...7,882,753

G

GTF2I repeat domain containing 1

increases expression

fullerene C60 results in increased expression of GTF2IRD1 mRNA

NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040

G

general transcription factor IIIC subunit 1

increases expression

fullerene C60 results in increased expression of GTF3C1 mRNA

NCBI chr 1:180,203,995...180,270,201
Ensembl chr 1:180,203,995...180,270,201

G

GTP binding protein 2

increases expression

fullerene C60 results in increased expression of GTPBP2 mRNA

NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241

G

G-2 and S-phase expressed 1

increases expression

fullerene C60 results in increased expression of GTSE1 mRNA

NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806

G

glycogen synthase 1

decreases expression

fullerene C60 results in decreased expression of GYS1 mRNA

NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292

G

glycogen synthase 2

decreases expression

fullerene C60 results in decreased expression of GYS2 mRNA

NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228

G

granzyme B

decreases expression

fullerene C60 results in decreased expression of GZMB mRNA

NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814

G

2-hydroxyacyl-CoA lyase 1

increases expression

fullerene C60 results in increased expression of HACL1 mRNA

NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027

G

hepcidin antimicrobial peptide

increases expression

fullerene C60 results in increased expression of HAMP mRNA

NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891

G

heart and neural crest derivatives expressed 1

decreases expression

fullerene C60 results in decreased expression of HAND1 mRNA

NCBI chr10:42,006,646...42,009,213
Ensembl chr10:42,006,651...42,009,213

G

hyaluronan and proteoglycan link protein 4

decreases expression

fullerene C60 results in decreased expression of HAPLN4 mRNA

NCBI chr16:19,333,106...19,341,243
Ensembl chr16:19,333,106...19,341,243

G

HAUS augmin-like complex, subunit 7

increases expression

fullerene C60 results in increased expression of HAUS7 mRNA

NCBI chr X:151,154,979...151,174,441
Ensembl chr X:151,154,979...151,180,577

G

hepatitis A virus cellular receptor 1

decreases expression

fullerene C60 results in decreased expression of HAVCR1 mRNA

NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698

G

hepatitis A virus cellular receptor 2

decreases expression

fullerene C60 results in decreased expression of HAVCR2 mRNA

NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137

G

hemoglobin subunit epsilon 1

decreases expression

fullerene C60 results in decreased expression of HBE1 mRNA

NCBI chr 1:158,282,931...158,458,855
Ensembl chr 1:158,282,936...158,284,391

G

hypocretin neuropeptide precursor

increases expression

fullerene C60 results in increased expression of HCRT mRNA

NCBI chr10:85,689,979...85,691,214
Ensembl chr10:85,689,465...85,691,210

G

histone deacetylase 1

decreases expression

fullerene C60 results in decreased expression of HDAC1 mRNA

NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111

G

histone deacetylase 2

decreases expression

fullerene C60 results in decreased expression of HDAC2 mRNA

NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609

G

histone deacetylase 5

decreases expression

fullerene C60 results in decreased expression of HDAC5 mRNA

NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235

G

histone deacetylase 7

increases expression

fullerene C60 results in increased expression of HDAC7 mRNA

NCBI chr 7:128,923,918...128,961,926
Ensembl chr 7:128,923,920...128,962,072

G

HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2

decreases expression

fullerene C60 results in decreased expression of HECW2 mRNA

NCBI chr 9:55,359,462...55,753,106
Ensembl chr 9:55,365,203...55,580,327

G

helicase with zinc finger 2

increases expression

fullerene C60 results in increased expression of HELZ2 mRNA

NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159

G

hes family bHLH transcription factor 3

decreases expression

fullerene C60 results in decreased expression of HES3 mRNA

NCBI chr 5:162,793,611...162,799,578
Ensembl chr 5:162,794,367...162,796,261

G

hes family bHLH transcription factor 5

affects expression

fullerene C60 affects the expression of HES5 mRNA

NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001

G

hypoxia inducible factor 3 subunit alpha

decreases expression

fullerene C60 results in decreased expression of HIF3A mRNA

NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758

G

histidine triad nucleotide binding protein 3

increases expression

fullerene C60 results in increased expression of HINT3 mRNA

NCBI chr 1:27,035,936...27,045,799
Ensembl chr 1:27,035,905...27,047,721

G

huntingtin interacting protein 1 related

increases expression

fullerene C60 results in increased expression of HIP1R mRNA

NCBI chr12:32,590,164...32,618,841
Ensembl chr12:32,590,165...32,618,734

G

histone cluster 1 H2B family member O

increases expression

fullerene C60 results in increased expression of H2BC15 mRNA

NCBI chr17:42,716,433...42,718,046
Ensembl chr17:42,673,067...42,718,095
Ensembl chr17:42,673,067...42,718,095

G

histone cluster 2 H2B family member E

increases expression

fullerene C60 results in increased expression of HIST2H2BE mRNA

NCBI chr 2:183,780,583...183,783,030

G

HIVEP zinc finger 1

increases expression

fullerene C60 results in increased expression of HIVEP1 mRNA

NCBI chr17:22,585,016...22,714,517
Ensembl chr17:22,585,016...22,711,956

G

Holliday junction recognition protein

decreases expression

fullerene C60 results in decreased expression of HJURP mRNA

NCBI chr 9:88,853,379...88,867,730
Ensembl chr 9:88,853,386...88,867,728

G

hemojuvelin BMP co-receptor

increases expression

fullerene C60 results in increased expression of HJV mRNA

NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850

G

hexokinase 1

increases expression

fullerene C60 results in increased expression of HK1 mRNA

NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131

G

holocarboxylase synthetase

decreases expression

fullerene C60 results in decreased expression of HLCS mRNA

NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222

G

high mobility group box 1

increases secretion
multiple interactions

fullerene C60 results in increased secretion of HMGB1 protein
2',3'-dialdehyde ATP inhibits the reaction [fullerene C60 results in increased secretion of HMGB1 protein]; [[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein] which results in increased expression of RAC1 protein; [fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein; Adenosine Triphosphate promotes the reaction [fullerene C60 results in increased secretion of HMGB1 protein]; fullerene C60 results in increased localization of and results in increased secretion of HMGB1 protein; P2RX7 protein affects the reaction [fullerene C60 results in increased secretion of HMGB1 protein]

NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565
Ensembl chr16:5,901,586...5,978,565

G

3-hydroxy-3-methylglutaryl-CoA lyase

decreases expression

fullerene C60 results in decreased expression of HMGCL mRNA

NCBI chr 5:148,178,203...148,192,072
Ensembl chr 5:148,178,252...148,192,068

G

high mobility group nucleosome binding domain 1

decreases expression

fullerene C60 results in decreased expression of HMGN1 mRNA

NCBI chr11:35,422,328...35,428,247
Ensembl chr11:35,422,328...35,428,254

G

H6 family homeobox 2

decreases expression

fullerene C60 results in decreased expression of HMX2 mRNA

NCBI chr 1:186,319,110...186,326,771
Ensembl chr 1:186,319,110...186,326,771

G

hepatocyte nuclear factor 4, alpha

decreases expression

fullerene C60 results in decreased expression of HNF4A mRNA

NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320

G

heterogeneous nuclear ribonucleoprotein L-like

increases expression

fullerene C60 results in increased expression of HNRNPLL mRNA

NCBI chr 6:14,969,953...15,000,574
Ensembl chr 6:14,970,057...14,999,745

G

4-hydroxy-2-oxoglutarate aldolase 1

decreases expression

fullerene C60 results in decreased expression of HOGA1 mRNA

NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:240,857,126...240,884,568

G

HOP homeobox

decreases expression

fullerene C60 results in decreased expression of HOPX mRNA

NCBI chr14:31,055,912...31,082,909
Ensembl chr14:31,075,148...31,082,909

G

homeo box C5

decreases expression

fullerene C60 results in decreased expression of HOXC5 mRNA

NCBI chr 7:134,150,988...134,154,410
Ensembl chr 7:134,150,988...134,154,410

G

hippocalcin-like 1

increases expression

fullerene C60 results in increased expression of HPCAL1 mRNA

NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687

G

hepsin

increases expression

fullerene C60 results in increased expression of HPN mRNA

NCBI chr 1:86,337,085...86,352,785
Ensembl chr 1:86,337,087...86,352,811

G

HPS1, biogenesis of lysosomal organelles complex 3 subunit 1

increases expression

fullerene C60 results in increased expression of HPS1 mRNA

NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268

G

histamine receptor H4

decreases expression

fullerene C60 results in decreased expression of HRH4 mRNA

NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345

G

heparan sulfate 6-O-sulfotransferase 1

increases expression

fullerene C60 results in increased expression of HS6ST1 mRNA

NCBI chr 9:38,283,502...38,322,684
Ensembl chr 9:38,282,395...38,322,683

G

hydroxysteroid 11-beta dehydrogenase 2

decreases expression

fullerene C60 results in decreased expression of HSD11B2 mRNA

NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899

G

heat shock protein family A (Hsp70) member 12B

increases expression

fullerene C60 results in increased expression of HSPA12B mRNA

NCBI chr 3:118,346,372...118,364,374
Ensembl chr 3:118,346,354...118,364,737

G

heat shock protein family A (Hsp70) member 1A

affects expression

fullerene C60 affects the expression of HSPA1A mRNA

NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227

G

heat shock protein family A (Hsp70) member 1 like

decreases expression

fullerene C60 results in decreased expression of HSPA1L mRNA

NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571

G

heat shock protein family A (Hsp70) member 8

increases expression

fullerene C60 results in increased expression of HSPA8 mRNA

NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259

G

heat shock protein family B (small) member 3

decreases expression

fullerene C60 results in decreased expression of HSPB3 mRNA

NCBI chr 2:45,295,285...45,295,999
Ensembl chr 2:45,295,053...45,296,145

G

heat shock protein family B (small) member 7

decreases expression

fullerene C60 results in decreased expression of HSPB7 mRNA

NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266

G

heat shock protein family D (Hsp60) member 1 like 2

increases expression

fullerene C60 results in increased expression of HSPD1L2 mRNA

NCBI chr 5:107,131,587...107,131,895
Ensembl chr 5:107,131,587...107,131,895

G

5-hydroxytryptamine (serotonin) receptor 5B

decreases expression

fullerene C60 results in decreased expression of HTR5B mRNA

NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835

G

HtrA serine peptidase 3

increases expression

fullerene C60 results in increased expression of HTRA3 mRNA

NCBI chr14:75,068,917...75,097,315
Ensembl chr14:75,068,917...75,097,315

G

hyaluronidase 2

decreases expression

fullerene C60 results in decreased expression of HYAL2 mRNA

NCBI chr 8:108,241,895...108,246,853
Ensembl chr 8:108,243,133...108,246,850

G

hydroxylysine kinase

decreases expression

fullerene C60 results in decreased expression of HYKK mRNA

NCBI chr 8:55,315,919...55,339,720
Ensembl chr 8:55,315,969...55,337,339

G

isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta

decreases expression

fullerene C60 results in decreased expression of IDH3B mRNA

NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982

G

isopentenyl-diphosphate delta isomerase 1

increases expression

fullerene C60 results in increased expression of IDI1 mRNA

NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357

G

immediate early response 5-like

increases expression

fullerene C60 results in increased expression of IER5L mRNA

NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647

G

intermediate filament family orphan 1

increases expression

fullerene C60 results in increased expression of IFFO1 mRNA

NCBI chr 4:157,945,075...157,962,302
Ensembl chr 4:157,945,107...157,962,302

G

IFI30, lysosomal thiol reductase

decreases expression

fullerene C60 results in decreased expression of IFI30 mRNA

NCBI chr16:18,675,590...18,679,655
Ensembl chr16:18,675,613...18,681,175

G

interferon gamma

increases secretion

fullerene C60 results in increased secretion of IFNG protein

NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375

G

intraflagellar transport 27

decreases expression

fullerene C60 results in decreased expression of IFT27 mRNA

NCBI chr 7:109,738,622...109,754,416
Ensembl chr 7:109,738,622...109,754,416

G

intraflagellar transport 43

decreases expression

fullerene C60 results in decreased expression of IFT43 mRNA

NCBI chr 6:105,729,734...105,806,257
Ensembl chr 6:105,729,792...105,806,257

G

intraflagellar transport associated protein

decreases expression

fullerene C60 results in decreased expression of IFTAP mRNA

NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547

G

insulin-like growth factor 1

decreases expression

fullerene C60 results in decreased expression of IGF1 mRNA

NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296

G

insulin-like growth factor binding protein 1

decreases expression

fullerene C60 results in decreased expression of IGFBP1 mRNA

NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482

G

insulin-like growth factor binding protein 3

decreases expression

fullerene C60 results in decreased expression of IGFBP3 mRNA

NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083

G

insulin-like growth factor binding protein 5

decreases expression

fullerene C60 results in decreased expression of IGFBP5 mRNA

NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156

G

immunoglobulin mu DNA binding protein 2

increases expression

fullerene C60 results in increased expression of IGHMBP2 mRNA

NCBI chr 1:200,506,641...200,529,293
Ensembl chr 1:200,506,338...200,529,514

G

immunoglobulin superfamily, member 3

decreases expression

fullerene C60 results in decreased expression of IGSF3 mRNA

NCBI chr 2:188,811,394...188,899,645
Ensembl chr 2:188,811,380...188,899,645

G

interleukin 10

increases secretion

fullerene C60 results in increased secretion of IL10 protein

NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313

G

interleukin 17 receptor A

increases expression

fullerene C60 results in increased expression of IL17RA mRNA

NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174

G

interleukin 1 beta

decreases expression

fullerene C60 results in decreased expression of IL1B mRNA

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 2

increases secretion

fullerene C60 results in increased secretion of IL2 protein

NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566

G

interleukin 21 receptor

increases expression

fullerene C60 results in increased expression of IL21R mRNA

NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522

G

interleukin 22 receptor subunit alpha 1

decreases expression

fullerene C60 results in decreased expression of IL22RA1 mRNA

NCBI chr 5:147,961,496...147,986,296
Ensembl chr 5:147,961,349...147,986,296

G

interleukin 2 receptor subunit gamma

decreases expression

fullerene C60 results in decreased expression of IL2RG mRNA

NCBI chr X:66,395,330...66,399,026
Ensembl chr X:66,392,542...66,399,823

G

interleukin 33

decreases expression

fullerene C60 results in decreased expression of IL33 mRNA

NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373

G

interleukin 4 receptor

increases expression

fullerene C60 results in increased expression of IL4RA mRNA

NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980

G

interleukin 6

multiple interactions
increases secretion

fullerene C60 inhibits the reaction [ALB protein modified form results in increased expression of IL6 protein]
fullerene C60 results in increased secretion of IL6 protein

PMID:19376187 PMID:20064541

NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178

G

ilvB acetolactate synthase like

decreases expression

fullerene C60 results in decreased expression of ILVBL mRNA

NCBI chr 7:11,039,870...11,049,924
Ensembl chr 7:11,039,871...11,049,924

G

inositol monophosphatase 2

decreases expression

fullerene C60 results in decreased expression of IMPA2 mRNA

NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641

G

inhibin subunit beta A

decreases expression

fullerene C60 results in decreased expression of INHBA mRNA

NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982

G

inositol polyphosphate-4-phosphatase type II B

decreases expression

fullerene C60 results in decreased expression of INPP4B mRNA

NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634

G

inositol polyphosphate phosphatase-like 1

increases expression

fullerene C60 results in increased expression of INPPL1 mRNA

NCBI chr 1:156,183,043...156,197,500
Ensembl chr 1:156,183,059...156,197,500

G

integrator complex subunit 7

decreases expression

fullerene C60 results in decreased expression of INTS7 mRNA

NCBI chr13:103,155,123...103,207,953
Ensembl chr13:103,155,090...103,208,592

G

importin 5

decreases expression

fullerene C60 results in decreased expression of IPO5 mRNA

NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126

G

IQ motif containing GTPase activating protein 3

decreases expression

fullerene C60 results in decreased expression of IQGAP3 mRNA

NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956

G

interleukin-1 receptor-associated kinase 1 binding protein 1

decreases expression

fullerene C60 results in decreased expression of IRAK1BP1 mRNA

NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289

G

interferon regulatory factor 2 binding protein-like

decreases expression

fullerene C60 results in decreased expression of IRF2BPL mRNA

NCBI chr 6:106,527,179...106,531,294
Ensembl chr 6:106,528,053...106,530,401

G

interferon regulatory factor 7

decreases expression

fullerene C60 results in decreased expression of IRF7 mRNA

NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832

G

iroquois homeobox 1

increases expression

fullerene C60 results in increased expression of IRX1 mRNA

NCBI chr 1:31,294,615...31,300,444
Ensembl chr 1:31,294,615...31,300,444

G

iroquois homeobox 3

increases expression

fullerene C60 results in increased expression of IRX3 mRNA

NCBI chr19:15,211,882...15,215,317
Ensembl chr19:15,211,878...15,215,317

G

iron-sulfur cluster assembly 1

decreases expression

fullerene C60 results in decreased expression of ISCA1 mRNA

NCBI chr17:4,905,291...4,917,955
Ensembl chr17:4,905,287...4,917,955

G

integrin subunit alpha 7

decreases expression

fullerene C60 results in decreased expression of ITGA7 mRNA

NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450

G

integrin subunit alpha M

increases expression

fullerene C60 results in increased expression of ITGAM mRNA

NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503

G

integrin subunit beta 1 binding protein 2

decreases expression

fullerene C60 results in decreased expression of ITGB1BP2 mRNA

NCBI chr X:66,572,537...66,577,174
Ensembl chr X:66,572,537...66,577,174

G

integrin subunit beta 3

decreases expression

fullerene C60 results in decreased expression of ITGB3 mRNA

NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679

G

inositol 1,4,5-trisphosphate receptor, type 3

increases expression

fullerene C60 results in increased expression of ITPR3 mRNA

NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337

G

intersectin 1

increases expression

fullerene C60 results in increased expression of ITSN1 mRNA

NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645

G

isovaleryl-CoA dehydrogenase

increases expression

fullerene C60 results in increased expression of IVD mRNA

NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:105,851,683...105,872,575

G

jade family PHD finger 2

decreases expression

fullerene C60 results in decreased expression of JADE2 mRNA

NCBI chr10:36,075,239...36,124,210
Ensembl chr10:36,078,917...36,116,984

G

jagged canonical Notch ligand 2

increases expression

fullerene C60 results in increased expression of JAG2 mRNA

NCBI chr 6:131,983,059...132,005,665
Ensembl chr 6:131,983,056...132,005,818

G

joining chain of multimeric IgA and IgM

decreases expression

fullerene C60 results in decreased expression of JCHAIN mRNA

NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298

G

junctophilin 1

decreases expression

fullerene C60 results in decreased expression of JPH1 mRNA

NCBI chr 5:2,030,227...2,137,171
Ensembl chr 5:2,030,281...2,125,284

G

JunB proto-oncogene, AP-1 transcription factor subunit

increases expression

fullerene C60 results in increased expression of JUNB mRNA

NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035

G

JunD proto-oncogene, AP-1 transcription factor subunit

increases expression

fullerene C60 results in increased expression of JUND mRNA

NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799

G

junction plakoglobin

increases expression

fullerene C60 results in increased expression of JUP mRNA

NCBI chr10:85,300,438...85,327,378
Ensembl chr10:85,300,440...85,327,057

G

kalirin, RhoGEF kinase

decreases expression

fullerene C60 results in decreased expression of KALRN mRNA

NCBI chr11:66,198,155...66,803,166
Ensembl chr11:66,198,173...66,797,610

G

KAT8 regulatory NSL complex subunit 3

increases expression

fullerene C60 results in increased expression of KANSL3 mRNA

NCBI chr 9:38,562,170...38,605,757
Ensembl chr 9:38,562,177...38,605,692

G

lysine acetyltransferase 14

decreases expression

fullerene C60 results in decreased expression of KAT14 mRNA

NCBI chr 3:131,736,430...131,781,732
Ensembl chr 3:131,736,549...131,781,706

G

potassium voltage-gated channel modifier subfamily G member 2

decreases expression

fullerene C60 results in decreased expression of KCNG2 mRNA

NCBI chr18:73,742,224...73,810,420
Ensembl chr18:73,743,074...73,808,723

G

potassium calcium-activated channel subfamily N member 3

increases expression

fullerene C60 results in increased expression of KCNN3 mRNA

NCBI chr 2:174,929,846...175,088,910
Ensembl chr 2:174,936,629...175,081,145

G

potassium voltage-gated channel subfamily Q member 1

increases expression

fullerene C60 results in increased expression of KCNQ1 mRNA

NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669

G

potassium channel tetramerization domain containing 13

decreases expression

fullerene C60 results in decreased expression of KCTD13 mRNA

NCBI chr 1:181,534,534...181,552,843
Ensembl chr 1:181,534,515...181,552,881

G

lysine demethylase 4C

affects expression

fullerene C60 affects the expression of KDM4C mRNA

NCBI chr 5:88,100,710...88,306,821
Ensembl chr 5:88,100,733...88,306,818

G

lysine demethylase 6B

increases expression

fullerene C60 results in increased expression of KDM6B mRNA

NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794

G

Kelch-like ECH-associated protein 1

increases expression

fullerene C60 results in increased expression of KEAP1 mRNA

NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862

G

Kell metallo-endopeptidase (Kell blood group)

decreases expression

fullerene C60 results in decreased expression of KEL mRNA

NCBI chr 4:70,568,241...70,585,666
Ensembl chr 4:70,568,243...70,585,631

G

KIAA1671 homolog

decreases expression

fullerene C60 results in decreased expression of KIAA1671 mRNA

NCBI chr12:43,409,479...43,552,152
Ensembl chr12:43,411,069...43,552,157

G

kinesin family member 20B

increases expression

fullerene C60 results in increased expression of KIF20B mRNA

NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787

G

kinesin family member 26A

increases expression

fullerene C60 results in increased expression of KIF26A mRNA

NCBI chr 6:131,214,839...131,250,874
Ensembl chr 6:131,214,861...131,250,320

G

kinesin family member C3

decreases expression
increases expression

fullerene C60 results in decreased expression of KIFC3 mRNA
fullerene C60 results in increased expression of KIFC3 mRNA

NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451

G

kirre like nephrin family adhesion molecule 1

decreases expression

fullerene C60 results in decreased expression of KIRREL1 mRNA

NCBI chr 2:172,521,644...172,615,057
Ensembl chr 2:172,525,245...172,615,299

G

kinesin light chain 3

increases expression

fullerene C60 results in increased expression of KLC3 mRNA

NCBI chr 1:79,045,842...79,055,809
Ensembl chr 1:79,045,844...79,055,416

G

KLF transcription factor 11

decreases expression

fullerene C60 results in decreased expression of KLF11 mRNA

NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550

G

KLF transcription factor 15

decreases expression

fullerene C60 results in decreased expression of KLF15 mRNA

NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374

G

KLF transcription factor 7

decreases expression

fullerene C60 results in decreased expression of KLF7 mRNA

NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261

G

KLF transcription factor 9

affects expression

fullerene C60 affects the expression of KLF9 mRNA

NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037

G

kelch domain containing 3

increases expression

fullerene C60 results in increased expression of KLHDC3 mRNA

NCBI chr 9:14,302,345...14,308,736
Ensembl chr 9:14,302,354...14,308,736

G

kelch domain containing 8B

increases expression

fullerene C60 results in increased expression of KLHDC8B mRNA

NCBI chr 8:109,141,594...109,146,584
Ensembl chr 8:109,141,594...109,146,918

G

kelch-like family member 18

increases expression

fullerene C60 results in increased expression of KLHL18 mRNA

NCBI chr 8:110,400,679...110,459,442
Ensembl chr 8:110,400,681...110,459,323

G

kelch-like family member 21

increases expression

fullerene C60 results in increased expression of KLHL21 mRNA

NCBI chr 5:162,514,888...162,523,545
Ensembl chr 5:162,514,765...162,523,545

G

kelch-like family member 22

increases expression

fullerene C60 results in increased expression of KLHL22 mRNA

NCBI chr11:83,190,891...83,231,746
Ensembl chr11:83,190,891...83,231,770

G

kelch-like family member 25

increases expression

fullerene C60 results in increased expression of KLHL25 mRNA

NCBI chr 1:129,724,894...129,750,142
Ensembl chr 1:129,722,026...129,750,227

G

kelch-like family, member 42

increases expression

fullerene C60 results in increased expression of KLHL42 mRNA

NCBI chr 4:179,999,655...180,027,283
Ensembl chr 4:180,004,580...180,027,283

G

kelch-like family member 7

decreases expression

fullerene C60 results in decreased expression of KLHL7 mRNA

NCBI chr 4:11,006,366...11,055,399
Ensembl chr 4:11,006,375...11,055,541

G

kallikrein 1

decreases expression

fullerene C60 results in decreased expression of KLK1 mRNA

NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754

G

kallikrein 1-related peptidase C10

decreases expression

fullerene C60 results in decreased expression of KLK1C10 mRNA

NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052

G

kallikrein related-peptidase 9

decreases expression

fullerene C60 results in decreased expression of KLK9 mRNA

NCBI chr 1:94,246,339...94,250,631
Ensembl chr 1:94,246,339...94,250,631

G

killer cell lectin like receptor C2

increases expression

fullerene C60 results in increased expression of KLRC2 mRNA

NCBI chr 4:163,122,700...163,133,843
Ensembl chr 4:163,122,704...163,133,843

G

lysine methyltransferase 5B

decreases expression

fullerene C60 results in decreased expression of KMT5B mRNA

NCBI chr 1:201,000,444...201,049,819
Ensembl chr 1:201,000,444...201,049,819

G

lysine methyltransferase 5C

increases expression

fullerene C60 results in increased expression of KMT5C mRNA

NCBI chr 1:69,099,531...69,107,145
Ensembl chr 1:69,099,539...69,107,145

G

keratin 13

decreases expression

fullerene C60 results in decreased expression of KRT13 mRNA

NCBI chr10:85,051,887...85,056,099
Ensembl chr10:85,051,889...85,056,084

G

keratin 8

increases expression

fullerene C60 results in increased expression of KRT8 mRNA

NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728

G

keratin associated protein 3-3

decreases expression

fullerene C60 results in decreased expression of KRTAP3-3 mRNA

NCBI chr10:84,511,459...84,511,758
Ensembl chr10:84,511,092...84,511,812
Ensembl chr10:84,511,092...84,511,812

G

kyphoscoliosis peptidase

decreases expression

fullerene C60 results in decreased expression of KY mRNA

NCBI chr 8:103,086,959...103,126,305
Ensembl chr 8:103,086,630...103,126,024

G

lactamase, beta

decreases expression

fullerene C60 results in decreased expression of LACTB mRNA

NCBI chr 8:67,571,504...67,587,592
Ensembl chr 8:67,571,500...67,587,539

G

laminin subunit beta 3

decreases expression

fullerene C60 results in decreased expression of LAMB3 mRNA

NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405

G

laminin subunit gamma 2

increases expression

fullerene C60 results in increased expression of LAMC2 mRNA

NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200

G

LanC like glutathione S-transferase 1

decreases expression

fullerene C60 results in decreased expression of LANCL1 mRNA

NCBI chr 9:68,515,052...68,548,646
Ensembl chr 9:68,518,574...68,548,628

G

La ribonucleoprotein 6, translational regulator

decreases expression

fullerene C60 results in decreased expression of LARP6 mRNA

NCBI chr 8:61,183,744...61,205,548
Ensembl chr 8:61,184,116...61,205,535

G

large tumor suppressor kinase 2

decreases expression

fullerene C60 results in decreased expression of LATS2 mRNA

NCBI chr15:31,825,068...31,877,193
Ensembl chr15:31,825,092...31,877,220

G

lipocalin 2

increases expression

fullerene C60 results in increased expression of LCN2 mRNA

NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095

G

LIM domain binding 3

increases expression

fullerene C60 results in increased expression of LDB3 mRNA

NCBI chr16:9,855,768...9,920,108
Ensembl chr16:9,855,927...9,918,532

G

lactate dehydrogenase B

increases expression

fullerene C60 results in increased expression of LDHB mRNA

NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403

G

LEM domain nuclear envelope protein 2

increases expression

fullerene C60 results in increased expression of LEMD2 mRNA

NCBI chr20:5,282,397...5,296,621
Ensembl chr20:5,282,397...5,296,626

G

LEM domain containing 3

decreases expression

fullerene C60 results in decreased expression of LEMD3 mRNA

NCBI chr 7:56,415,053...56,499,047
Ensembl chr 7:56,305,448...56,502,474

G

LHFPL tetraspan subfamily member 4

decreases expression

fullerene C60 results in decreased expression of LHFPL4 mRNA

NCBI chr 4:146,317,110...146,340,073
Ensembl chr 4:146,313,541...146,340,463

G

LHFPL tetraspan subfamily member 6

decreases expression

fullerene C60 results in decreased expression of LHFPL6 mRNA

NCBI chr 2:137,126,485...137,324,442
Ensembl chr 2:137,126,509...137,324,443

G

LIM homeobox 3

decreases expression

fullerene C60 results in decreased expression of LHX3 mRNA

NCBI chr 3:9,026,432...9,035,122
Ensembl chr 3:9,027,425...9,034,480

G

DNA ligase 3

decreases expression

fullerene C60 results in decreased expression of LIG3 mRNA

NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414

G

lens intrinsic membrane protein 2

decreases expression

fullerene C60 results in decreased expression of LIM2 mRNA

NCBI chr 1:93,837,597...93,843,769
Ensembl chr 1:93,837,597...93,843,769

G

LIM domain containing 2

decreases expression

fullerene C60 results in decreased expression of LIMD2 mRNA

NCBI chr10:91,090,279...91,092,772
Ensembl chr10:91,090,280...91,092,775

G

LIM domain kinase 1

decreases expression

fullerene C60 results in decreased expression of LIMK1 mRNA

NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606

G

lin-28 homolog A

decreases expression

fullerene C60 results in decreased expression of LIN28A mRNA

NCBI chr 5:146,227,119...146,244,122
Ensembl chr 5:146,227,119...146,244,122

G

lipase C, hepatic type

decreases expression

fullerene C60 results in decreased expression of LIPC mRNA

NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464

G

Lipogenin

increases expression

fullerene C60 results in increased expression of LIPOGENIN mRNA

NCBI chr 4:57,356,298...57,357,553

G

limb and CNS expressed 1 like

increases expression

fullerene C60 results in increased expression of LIX1L mRNA

NCBI chr 2:184,136,018...184,161,918
Ensembl chr 2:184,136,038...184,161,916

G

LLGL scribble cell polarity complex component 1

increases expression

fullerene C60 results in increased expression of LLGL1 mRNA

NCBI chr10:45,379,423...45,394,096
Ensembl chr10:45,379,515...45,394,094

G